JPH039888B2 - - Google Patents
Info
- Publication number
- JPH039888B2 JPH039888B2 JP3817183A JP3817183A JPH039888B2 JP H039888 B2 JPH039888 B2 JP H039888B2 JP 3817183 A JP3817183 A JP 3817183A JP 3817183 A JP3817183 A JP 3817183A JP H039888 B2 JPH039888 B2 JP H039888B2
- Authority
- JP
- Japan
- Prior art keywords
- pgd
- alcohol
- compound
- group
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 68
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 61
- 150000003180 prostaglandins Chemical class 0.000 claims description 14
- 229920000858 Cyclodextrin Polymers 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- UQOQENZZLBSFKO-POPPZSFYSA-N prostaglandin J2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)C=CC1=O UQOQENZZLBSFKO-POPPZSFYSA-N 0.000 claims description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 54
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 45
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 35
- 239000000203 mixture Substances 0.000 description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- -1 PGF and PGE Chemical class 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- 238000004809 thin layer chromatography Methods 0.000 description 13
- 238000005481 NMR spectroscopy Methods 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 8
- 230000000704 physical effect Effects 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- DZUXGQBLFALXCR-UHFFFAOYSA-N (+)-(9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprost-13-en-1-oic acid Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CCCCCCC(O)=O DZUXGQBLFALXCR-UHFFFAOYSA-N 0.000 description 4
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 239000003701 inert diluent Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 4
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 4
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000002723 alicyclic group Chemical group 0.000 description 3
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 3
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 3
- 229960004853 betadex Drugs 0.000 description 3
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008247 solid mixture Substances 0.000 description 3
- 125000004187 tetrahydropyran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 206010061523 Lip and/or oral cavity cancer Diseases 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- 208000003445 Mouth Neoplasms Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- 239000004227 calcium gluconate Substances 0.000 description 2
- 235000013927 calcium gluconate Nutrition 0.000 description 2
- 229960004494 calcium gluconate Drugs 0.000 description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229940117975 chromium trioxide Drugs 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000012457 nonaqueous media Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 230000016160 smooth muscle contraction Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YCQANBSROMMIQP-UHFFFAOYSA-N 1-chloropyrrolidine-2,5-dione;methylsulfanylmethane Chemical compound CSC.ClN1C(=O)CCC1=O YCQANBSROMMIQP-UHFFFAOYSA-N 0.000 description 1
- 125000006219 1-ethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- ZEMOZGYCFBTCMC-MBNOUSKYSA-N 16,16-dimethyl-PGD2 Chemical compound CCCCC(C)(C)[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O ZEMOZGYCFBTCMC-MBNOUSKYSA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- 239000012027 Collins reagent Substances 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000006809 Jones oxidation reaction Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-Chlorosuccinimide Substances ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical class [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- ZJQALQKVUGRLFF-UHFFFAOYSA-N [Cl].CSC Chemical compound [Cl].CSC ZJQALQKVUGRLFF-UHFFFAOYSA-N 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000003182 bronchodilatating effect Effects 0.000 description 1
- 230000007883 bronchodilation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- VTHIKKVKIVQWHV-UHFFFAOYSA-N chromium(6+) oxygen(2-) pyridine Chemical class [O-2].[O-2].[O-2].[Cr+6].C1=CC=NC=C1 VTHIKKVKIVQWHV-UHFFFAOYSA-N 0.000 description 1
- AHXGRMIPHCAXFP-UHFFFAOYSA-L chromyl dichloride Chemical compound Cl[Cr](Cl)(=O)=O AHXGRMIPHCAXFP-UHFFFAOYSA-L 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000000754 myometrium Anatomy 0.000 description 1
- QPNOPWWAMGQISP-UHFFFAOYSA-N n,n'-dicyclohexylmethanediimine;methylsulfinylmethane Chemical compound CS(C)=O.C1CCCCC1N=C=NC1CCCCC1 QPNOPWWAMGQISP-UHFFFAOYSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- AAHFRWRQQDVWPX-UHFFFAOYSA-N prop-2-ene-1-sulfonyl chloride Chemical compound ClS(=O)(=O)CC=C AAHFRWRQQDVWPX-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CIMMACURCPXICP-PNQRDDRVSA-N prostaglandin D1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)[C@@H](O)CC1=O CIMMACURCPXICP-PNQRDDRVSA-N 0.000 description 1
- BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 description 1
- UKVVPDHLUHAJNZ-PMACEKPBSA-N prostane Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC UKVVPDHLUHAJNZ-PMACEKPBSA-N 0.000 description 1
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- NPRDHMWYZHSAHR-UHFFFAOYSA-N pyridine;trioxochromium Chemical compound O=[Cr](=O)=O.C1=CC=NC=C1.C1=CC=NC=C1 NPRDHMWYZHSAHR-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229940032330 sulfuric acid Drugs 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 125000002306 tributylsilyl group Chemical group C(CCC)[Si](CCCC)(CCCC)* 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
æ¬çºæã¯æ°èŠãªããã¹ã¿ã°ã©ã³ãžã³ïŒ€é¡äŒŒåå
ç©ã«é¢ããã ããã¹ã¿ã°ã©ã³ãžã³ã¯æ¬¡ã®æ§é ããã€ããã¹ã¿
ã³é žã®èªå°äœã§ããã çš®ã ã®ã¿ã€ãã®ããã¹ã¿ã°ã©ã³ãžã³ãç¥ãããŠã
ãããã®ã¿ã€ãã¯èç°åŒç°ã®æ§é ãšçœ®æåºã«äŒŒå
ãããäŸãã°ãããã¹ã¿ã°ã©ã³ãžã³ïŒŠïŒPGFïŒã
ïŒPGEïŒåã³ïŒ€ïŒPGDïŒã®èç°åŒç°ã¯ãããã
次ã®æ§é ããã€ã
ç©ã«é¢ããã ããã¹ã¿ã°ã©ã³ãžã³ã¯æ¬¡ã®æ§é ããã€ããã¹ã¿
ã³é žã®èªå°äœã§ããã çš®ã ã®ã¿ã€ãã®ããã¹ã¿ã°ã©ã³ãžã³ãç¥ãããŠã
ãããã®ã¿ã€ãã¯èç°åŒç°ã®æ§é ãšçœ®æåºã«äŒŒå
ãããäŸãã°ãããã¹ã¿ã°ã©ã³ãžã³ïŒŠïŒPGFïŒã
ïŒPGEïŒåã³ïŒ€ïŒPGDïŒã®èç°åŒç°ã¯ãããã
次ã®æ§é ããã€ã
ãåŒãåã³
ãåŒã
åèšã®æ§é åŒäžãããã¯æ¬æ现æžäžã®ä»ã®æ§é
åŒäžã®ç¹ç·ã¯ãäžè¬çã«èªããããŠããåœåæ³ã®
èŠåã«åŸããããã«ã€ããŠããåºãç°å¹³é¢ã®ãã
ãåŽããªãã¡Î±âé 眮ã§ãã倪ç·ãã¯ããã«ã€ã
ãŠããåºãç°å¹³é¢ã®ååŽããªãã¡Î²âé 眮ã§ã
ããæ³¢ç·ãã¯ããã«ã€ããŠããåºãαâãŸãã¯Î²
âé 眮ããŸãã¯ãããã®æ··åç©ã§ããããšã瀺
ãã ãããã®ååç©ã¯èç°åŒç°ã®ïŒäœãš12äœã«ã€ã
ãŠããåŽéäžã®äºéçµåã®äœçœ®ã«ãã€ãŠå¯åé¡ã
ãããPGâïŒååç©ã¯C13âC14éã«ãã©ã³ã¹äº
éçµåïŒãã©ã³ã¹âÎ13ïŒããã¡PGâïŒååç©ã¯
C5âC6éã¯ã·ã¹äºéçµåãšC13âC14éã«ãã©ã³ã¹
äºéçµåïŒã·ã¹âÎ5ããã©ã³ã¹âÎ13ïŒããã€ãŠ
ãããäŸãã°ãããã¹ã¿ã°ã©ã³ãžã³D1ïŒPGD1ïŒ
åã³ããã¹ã¿ã°ã©ã³ãžã³D2ïŒPGD2ïŒã¯ãããã
ã次ã®æ§é åŒã§ç€ºãããã åã³ æŽã«ããã¹ã¿ã°ã©ã³ãžã³ã®èç°åŒç°ã®12äœã«ã€
ããŠããèèªæåºããïŒã€ãŸãã¯ãã以äžã®ã¡ã
ã¬ã³åºãé€å»ããããšãããã®ååç©ã¯ãææ©åœ
åæ³ã®äžè¬åã«åŸã€ãŠãã«âããã¹ã¿ã°ã©ã³ãžã³
ãšããŠç¥ãããŠãããé€å»ãããã¡ãã¬ã³åºã®æ°
ã¯ããã«ãã®æ¥é èªã®åã«ãžâãããã¯ããªâç
ãã€ããŠç€ºãããã ããã¹ã¿ã°ã©ã³ãžã³ã¯äžè¬ã«è¬ççæ§è³ªãæã
ããäŸãã°ãããã¯ãå¹³æ»çã®åçž®ãåºæ¿ããäœ
çšãè¡å§éäžäœçšãå©å°¿äœçšãæ°ç®¡æ¯æ¡åŒµäœçšã
èèªå解é»å®³äœçšãè¡å°æ¿åéæå¶äœçšãèé žå
æ³æå¶äœçšãæããããããã€ãŠé«è¡å§çãè¡æ
çãåæ¯åã³èè žã®æœ°çã®æ²»çãåŠåš åºä¹³åç©ã®
ååš©èªçºåã³äžçµ¶ãåè硬åã®äºé²ããŸãã¯å©å°¿
å€ãšããŠæå¹ã§ããããããã¯ãåç©äœå ã®çäœ
å ãããã¹ã¿ãã©ã³ãžã³ãåæ³ããåçµç¹äžã«ã
ã埮éååšããè溶æ§ç©è³ªã§ããã æ¬çºæã¯ãè±åœç¹èš±ç¬¬1403838å·åã³ç¹éæ52
â89650å·åã³å51â143643å·æ现æžã«èšèŒãã
ãçºæãæ¹åãããã®ã§ããã è±åœç¹èš±ç¬¬1408383å·æ现æžã§ã¯ãPGDã®ïŒäœ
ã®ã«ã«ããã·ã«åºãããããã·ã¡ãã«åºã§çœ®æã
ãååç©ïŒä»¥äžãPGDã¢ã«ã³ãŒã«äœãšåŒã¶ãïŒå
ã³ãããã®é¡äŒŒååç©ãåºããã€éç¹å®çã«èšèŒ
ãããŠãããããã«ãããã®ååç©ãããã¹ã¿ã°
ã©ã³ãžã³ç¹æã«æ¢ç¥ãªè¬çäœçšãç¹ã«è¡å§éäžäœ
çšãå¹³æ»çã®åçž®ãåºæ¿ããäœçšãè¡å°æ¿åéæ
å¶äœçšåã³æ°ç®¡æ¯æ¡åŒµäœçšãæããŠããããšãæ
ããã«ãããŠãããããããªããPGDã¢ã«ã³ãŒ
ã«äœã®è£œé å®æœäŸåã³ç¹å®åãããååç©ã®é瀺
ã¯å šããªãç¶æ ã§ããã ç¹éæ52â89650å·æ现æžã§ããPGDã¢ã«ã³ãŒ
ã«äœåã³ãããã®ïŒäœã«ã€ããŠããæ°Žé žåºãè±æ°Ž
ãããC9âC10éã«äºéçµåãå°å ¥ãããååç©
ïŒä»¥äžãïŒâããªãã·âÎ9âPGDã¢ã«ã³ãŒã«äœãš
åŒã¶ãïŒåã³ãããã®é¡ååç©ãPGFãPGEçã®
ã¢ã«ã³ãŒã«äœãšäžè«žã«é瀺ãããŠã¯ãããããã®
èšèŒã¯åºç¯å²ãéç¹å®ã§ãããè¬çäœçšã®èšèŒã
ãããŸãã§ãããããã«è£œé å®æœäŸãç¹å®åãã
ãååç©ã®é瀺ãå šããªãã ç¹éæ51â143643å·æ现æžã§ã¯PGDã¢ã«ã³ãŒ
ã«äœåã³ãããã®é¡äŒŒååç©ããåºçºç©è³ªãšããŠ
èšèŒãããŠãããã®ã®ãPGFãPGEçã®ã¢ã«ã³
ãŒã«äœãå«ãåºç¯å²ãªååç©çŸ€ã®ã»ãã®äžéšãšã
ãŠé瀺ãããŠããã ãã§ããããã®ååç©ã®è¬ç
äœçšã補é å®æœäŸåã³ç¹å®åãããååç©ã®é瀺
ã¯å šããªãã ä»åãæã ã¯PGD2ã¢ã«ã³ãŒã«åã³ïŒâããªã
ã·âÎ9âPGD2ã¢ã«ã³ãŒã«ãæ°ãã«åæãããã
ãã®ååç©ãå šãæ°èŠãªè¬ççæ§è³ªïŒãã¡ããã
äžèšã®å è¡æè¡ã®æ现æžã«ãå šãèšèŒãããŠããª
ããããã€ãããã®æ现æžããã¯äºæããããšã
åºæ¥ãªãæ§è³ªïŒãããªãã¡æè «çäœçšãæããŠã
ãããšãèŠãåºããæ¬çºæãå®æããã åèšããå è¡æè¡æ现æžã§ã¯ãäžè¬ã®ããã¹ã¿
ã°ã©ã³ãžã³ã«ç¥ãããŠããè¬ççæ§è³ªãåã«è¿°ã¹
ãã«ãšã©ãŸããæè «çäœçšã«çç®ããåºé¡ã¯çç¡
ã§ããã ããªãã¡æ¬çºæã¯ãäžè¬åŒ ãåŒäžãããã¯ãåŒ
åŒäžã®ç¹ç·ã¯ãäžè¬çã«èªããããŠããåœåæ³ã®
èŠåã«åŸããããã«ã€ããŠããåºãç°å¹³é¢ã®ãã
ãåŽããªãã¡Î±âé 眮ã§ãã倪ç·ãã¯ããã«ã€ã
ãŠããåºãç°å¹³é¢ã®ååŽããªãã¡Î²âé 眮ã§ã
ããæ³¢ç·ãã¯ããã«ã€ããŠããåºãαâãŸãã¯Î²
âé 眮ããŸãã¯ãããã®æ··åç©ã§ããããšã瀺
ãã ãããã®ååç©ã¯èç°åŒç°ã®ïŒäœãš12äœã«ã€ã
ãŠããåŽéäžã®äºéçµåã®äœçœ®ã«ãã€ãŠå¯åé¡ã
ãããPGâïŒååç©ã¯C13âC14éã«ãã©ã³ã¹äº
éçµåïŒãã©ã³ã¹âÎ13ïŒããã¡PGâïŒååç©ã¯
C5âC6éã¯ã·ã¹äºéçµåãšC13âC14éã«ãã©ã³ã¹
äºéçµåïŒã·ã¹âÎ5ããã©ã³ã¹âÎ13ïŒããã€ãŠ
ãããäŸãã°ãããã¹ã¿ã°ã©ã³ãžã³D1ïŒPGD1ïŒ
åã³ããã¹ã¿ã°ã©ã³ãžã³D2ïŒPGD2ïŒã¯ãããã
ã次ã®æ§é åŒã§ç€ºãããã åã³ æŽã«ããã¹ã¿ã°ã©ã³ãžã³ã®èç°åŒç°ã®12äœã«ã€
ããŠããèèªæåºããïŒã€ãŸãã¯ãã以äžã®ã¡ã
ã¬ã³åºãé€å»ããããšãããã®ååç©ã¯ãææ©åœ
åæ³ã®äžè¬åã«åŸã€ãŠãã«âããã¹ã¿ã°ã©ã³ãžã³
ãšããŠç¥ãããŠãããé€å»ãããã¡ãã¬ã³åºã®æ°
ã¯ããã«ãã®æ¥é èªã®åã«ãžâãããã¯ããªâç
ãã€ããŠç€ºãããã ããã¹ã¿ã°ã©ã³ãžã³ã¯äžè¬ã«è¬ççæ§è³ªãæã
ããäŸãã°ãããã¯ãå¹³æ»çã®åçž®ãåºæ¿ããäœ
çšãè¡å§éäžäœçšãå©å°¿äœçšãæ°ç®¡æ¯æ¡åŒµäœçšã
èèªå解é»å®³äœçšãè¡å°æ¿åéæå¶äœçšãèé žå
æ³æå¶äœçšãæããããããã€ãŠé«è¡å§çãè¡æ
çãåæ¯åã³èè žã®æœ°çã®æ²»çãåŠåš åºä¹³åç©ã®
ååš©èªçºåã³äžçµ¶ãåè硬åã®äºé²ããŸãã¯å©å°¿
å€ãšããŠæå¹ã§ããããããã¯ãåç©äœå ã®çäœ
å ãããã¹ã¿ãã©ã³ãžã³ãåæ³ããåçµç¹äžã«ã
ã埮éååšããè溶æ§ç©è³ªã§ããã æ¬çºæã¯ãè±åœç¹èš±ç¬¬1403838å·åã³ç¹éæ52
â89650å·åã³å51â143643å·æ现æžã«èšèŒãã
ãçºæãæ¹åãããã®ã§ããã è±åœç¹èš±ç¬¬1408383å·æ现æžã§ã¯ãPGDã®ïŒäœ
ã®ã«ã«ããã·ã«åºãããããã·ã¡ãã«åºã§çœ®æã
ãååç©ïŒä»¥äžãPGDã¢ã«ã³ãŒã«äœãšåŒã¶ãïŒå
ã³ãããã®é¡äŒŒååç©ãåºããã€éç¹å®çã«èšèŒ
ãããŠãããããã«ãããã®ååç©ãããã¹ã¿ã°
ã©ã³ãžã³ç¹æã«æ¢ç¥ãªè¬çäœçšãç¹ã«è¡å§éäžäœ
çšãå¹³æ»çã®åçž®ãåºæ¿ããäœçšãè¡å°æ¿åéæ
å¶äœçšåã³æ°ç®¡æ¯æ¡åŒµäœçšãæããŠããããšãæ
ããã«ãããŠãããããããªããPGDã¢ã«ã³ãŒ
ã«äœã®è£œé å®æœäŸåã³ç¹å®åãããååç©ã®é瀺
ã¯å šããªãç¶æ ã§ããã ç¹éæ52â89650å·æ现æžã§ããPGDã¢ã«ã³ãŒ
ã«äœåã³ãããã®ïŒäœã«ã€ããŠããæ°Žé žåºãè±æ°Ž
ãããC9âC10éã«äºéçµåãå°å ¥ãããååç©
ïŒä»¥äžãïŒâããªãã·âÎ9âPGDã¢ã«ã³ãŒã«äœãš
åŒã¶ãïŒåã³ãããã®é¡ååç©ãPGFãPGEçã®
ã¢ã«ã³ãŒã«äœãšäžè«žã«é瀺ãããŠã¯ãããããã®
èšèŒã¯åºç¯å²ãéç¹å®ã§ãããè¬çäœçšã®èšèŒã
ãããŸãã§ãããããã«è£œé å®æœäŸãç¹å®åãã
ãååç©ã®é瀺ãå šããªãã ç¹éæ51â143643å·æ现æžã§ã¯PGDã¢ã«ã³ãŒ
ã«äœåã³ãããã®é¡äŒŒååç©ããåºçºç©è³ªãšããŠ
èšèŒãããŠãããã®ã®ãPGFãPGEçã®ã¢ã«ã³
ãŒã«äœãå«ãåºç¯å²ãªååç©çŸ€ã®ã»ãã®äžéšãšã
ãŠé瀺ãããŠããã ãã§ããããã®ååç©ã®è¬ç
äœçšã補é å®æœäŸåã³ç¹å®åãããååç©ã®é瀺
ã¯å šããªãã ä»åãæã ã¯PGD2ã¢ã«ã³ãŒã«åã³ïŒâããªã
ã·âÎ9âPGD2ã¢ã«ã³ãŒã«ãæ°ãã«åæãããã
ãã®ååç©ãå šãæ°èŠãªè¬ççæ§è³ªïŒãã¡ããã
äžèšã®å è¡æè¡ã®æ现æžã«ãå šãèšèŒãããŠããª
ããããã€ãããã®æ现æžããã¯äºæããããšã
åºæ¥ãªãæ§è³ªïŒãããªãã¡æè «çäœçšãæããŠã
ãããšãèŠãåºããæ¬çºæãå®æããã åèšããå è¡æè¡æ现æžã§ã¯ãäžè¬ã®ããã¹ã¿
ã°ã©ã³ãžã³ã«ç¥ãããŠããè¬ççæ§è³ªãåã«è¿°ã¹
ãã«ãšã©ãŸããæè «çäœçšã«çç®ããåºé¡ã¯çç¡
ã§ããã ããªãã¡æ¬çºæã¯ãäžè¬åŒ ãåŒäžãããã¯ãåŒ
ãåŒã
ãŸãã¯
ãåŒã
ã§ç€ºãããåºãè¡šãããR1ã¯ççŽ æ°ïŒãïŒã®çŽ
éãŸãã¯åæéã¢ã«ãã«åºãè¡šãããC5âC6é
ã®äºéçµåã¯ïŒºãè¡šãããC13âC14éã®äºéçµå
ã¯ïŒ¥ãè¡šãããåŒïŒïŒã«ãããŠãC9âC10éã®
äºéçµåã¯ïŒºãè¡šãããã ã§ç€ºãããPGDé¡äŒŒååç©ãåã³ãããã®ã·ã¯
ãããã¹ããªã³å æ¥ååç©ã«é¢ããã äžè¬åŒïŒïŒã 瀺ãããããã¹ã¿ã°ã©ã³ãžã³ïŒ€
é¡äŒŒååç©ãåã³ãããã®ã·ã¯ãããã¹ããªã³å
æ¥ååç©ã¯ãããã¹ã¿ã°ã©ã³ãžã³ã«ç¹æã®è¬çäœ
çšãäŸãã°è¡å§éäžäœçšãè¡å°æ¿åéæå¶äœçšã
è¡å°æ¿åéæå¶äœçšãåå®®çã®åçž®ãåºæ¿ããäœ
çšãäžç¢äœçšãå šã瀺ããªããããŸãã¯ãããã®
äœçšãéåžžã«åŒ±ããã®ã§ããã«ãããããããæ
è «çäœçšãé©ãã»ã©åŒ·åã§ããããæ¯æ§ã極ããŠ
å°ãªãããšãèŠãåºãããïŒãããã®ååç©ã匷
åãªæè «çäœçšãæããŠããããšã¯ãåèšããå
è¡æè¡ã®æ现æžäžã«ã¯å šãèšèŒãããŠããªããïŒã
åŸã€ãŠäžè¬åŒïŒïŒã§ç€ºãããããã¹ã¿ã°ã©ã³ãž
ã³ïŒ€é¡äŒŒååç©åã³ãããã®ã·ã¯ãããã¹ããªã³
å æ¥ååç©ã¯è «çãäŸãã°çœè¡ç åã³åºåã¬ã³ã«
察ããäºé²å¹æãæ²»çå¹æåã³å»¶åœå¹æãç®çãš
ãããéåžžã«æå¹ã§çæ³çãªæè «çå€ãšããŠçšã
ãããšãã§ããã äŸãã°ãå®éšå®€ã®å®éšã§ã¯ãããã®å£åºã¬ã³çŽ°
èïŒKB cellïŒãçšãããin vitroã§ã®å¢æ®æå¶
è©Šéšã«ãããŠãæ¬çºæååç©ã¯åªããæå¶å¹æã
瀺ããã以äžã«ãã®å®éšæ¹æ³ãšçµæã瀺ãã ããã®å£åºã¬ã³çŽ°èïŒKB cellïŒãçšããå¢æ®æ
å¶è©Šéš ïŒå®éšæ¹æ³ïŒ KB cellã10ïŒ ã®ä»çèå è¡æž å«æã®ã€ãŒã°ã«
MEMå¹é€æ¶²ã«å ããå¹é€æ¶²äžã®çŽ°èæ°ãïŒÃ
105åïŒmlã«èª¿æŽããæ¬çºæååç©ã®ãšã¿ããŒã«
溶液ãæçµæ¿åºŠ5ÎŒïœïŒmlåã³ãã以äžã®æ¿åºŠ
ïŒïŒç¹ïŒã«ãªãããã«å ããåŸã37âã§ïŒæ¥éé
眮å¹é€ãããå¯Ÿç §ãšãããšã¿ããŒã«0.1ïŒ ãå ã
ã现èå¹é€æ¶²ãåæ§ã«å¹é€ãããå¹é€åŸãããªã
ã³ãã«ãŒæè²æ³ã§æè²ãç现èæ°ã枬å®ããŠã察
ç §ã«å¯Ÿããæå¶çããIC50å€ïŒ50ïŒ å¢æ®æå¶æ¿
床ïŒãæ±ãããçµæãäžè¡šã«ç€ºãã
éãŸãã¯åæéã¢ã«ãã«åºãè¡šãããC5âC6é
ã®äºéçµåã¯ïŒºãè¡šãããC13âC14éã®äºéçµå
ã¯ïŒ¥ãè¡šãããåŒïŒïŒã«ãããŠãC9âC10éã®
äºéçµåã¯ïŒºãè¡šãããã ã§ç€ºãããPGDé¡äŒŒååç©ãåã³ãããã®ã·ã¯
ãããã¹ããªã³å æ¥ååç©ã«é¢ããã äžè¬åŒïŒïŒã 瀺ãããããã¹ã¿ã°ã©ã³ãžã³ïŒ€
é¡äŒŒååç©ãåã³ãããã®ã·ã¯ãããã¹ããªã³å
æ¥ååç©ã¯ãããã¹ã¿ã°ã©ã³ãžã³ã«ç¹æã®è¬çäœ
çšãäŸãã°è¡å§éäžäœçšãè¡å°æ¿åéæå¶äœçšã
è¡å°æ¿åéæå¶äœçšãåå®®çã®åçž®ãåºæ¿ããäœ
çšãäžç¢äœçšãå šã瀺ããªããããŸãã¯ãããã®
äœçšãéåžžã«åŒ±ããã®ã§ããã«ãããããããæ
è «çäœçšãé©ãã»ã©åŒ·åã§ããããæ¯æ§ã極ããŠ
å°ãªãããšãèŠãåºãããïŒãããã®ååç©ã匷
åãªæè «çäœçšãæããŠããããšã¯ãåèšããå
è¡æè¡ã®æ现æžäžã«ã¯å šãèšèŒãããŠããªããïŒã
åŸã€ãŠäžè¬åŒïŒïŒã§ç€ºãããããã¹ã¿ã°ã©ã³ãž
ã³ïŒ€é¡äŒŒååç©åã³ãããã®ã·ã¯ãããã¹ããªã³
å æ¥ååç©ã¯è «çãäŸãã°çœè¡ç åã³åºåã¬ã³ã«
察ããäºé²å¹æãæ²»çå¹æåã³å»¶åœå¹æãç®çãš
ãããéåžžã«æå¹ã§çæ³çãªæè «çå€ãšããŠçšã
ãããšãã§ããã äŸãã°ãå®éšå®€ã®å®éšã§ã¯ãããã®å£åºã¬ã³çŽ°
èïŒKB cellïŒãçšãããin vitroã§ã®å¢æ®æå¶
è©Šéšã«ãããŠãæ¬çºæååç©ã¯åªããæå¶å¹æã
瀺ããã以äžã«ãã®å®éšæ¹æ³ãšçµæã瀺ãã ããã®å£åºã¬ã³çŽ°èïŒKB cellïŒãçšããå¢æ®æ
å¶è©Šéš ïŒå®éšæ¹æ³ïŒ KB cellã10ïŒ ã®ä»çèå è¡æž å«æã®ã€ãŒã°ã«
MEMå¹é€æ¶²ã«å ããå¹é€æ¶²äžã®çŽ°èæ°ãïŒÃ
105åïŒmlã«èª¿æŽããæ¬çºæååç©ã®ãšã¿ããŒã«
溶液ãæçµæ¿åºŠ5ÎŒïœïŒmlåã³ãã以äžã®æ¿åºŠ
ïŒïŒç¹ïŒã«ãªãããã«å ããåŸã37âã§ïŒæ¥éé
眮å¹é€ãããå¯Ÿç §ãšãããšã¿ããŒã«0.1ïŒ ãå ã
ã现èå¹é€æ¶²ãåæ§ã«å¹é€ãããå¹é€åŸãããªã
ã³ãã«ãŒæè²æ³ã§æè²ãç现èæ°ã枬å®ããŠã察
ç §ã«å¯Ÿããæå¶çããIC50å€ïŒ50ïŒ å¢æ®æå¶æ¿
床ïŒãæ±ãããçµæãäžè¡šã«ç€ºãã
ãè¡šã
äžè¬åŒïŒïŒã§ç€ºãããååç©ã«ã¯ããã€ãã®
äžæççŽ ãååšãããäŸãã°äžè¬åŒïŒïŒã«ãã
ãŠããããåŒïŒïŒã§ç€ºãããåºãè¡šããåå
ç©ã«ã¯ãïŒåã®äžæäžå¿ïŒããªãã¡ãïŒäœãïŒ
äœã12äœåã³15äœã®ççŽ ååïŒãååšãããã
ãåŒïŒïŒã§ç€ºãããåºãè¡šããååç©ã§ã¯ãïŒ
äœã12äœåã³15äœã®ççŽ ååãäžæççŽ ã§ããã
ããã«R1ãè¡šããã¢ã«ãã«åºãåæéã§ããå Ž
åã«ã¯ãä»ã®äžæççŽ ãçããå¯èœæ§ããããã
ãããªãããæ¬çºæã®äžè¬åŒïŒïŒã§ç€ºãããå
åç©ã¯ãäžæççŽ ã«ãã€ãŠãŠçããåã ã®ç°æ§äœ
åã³ãããã®æ··åç©ããå«æãããã®ã§ããã äžè¬åŒïŒïŒã«ãããŠãR1ãè¡šããççŽ æ°ïŒ
ãïŒã®ã¢ã«ãã«åºãšããŠã¯ãã¡ãã«ããšãã«ãã
ããã«ãããã«ããã³ãã«ãããã·ã«ãããã
ã«ããªã¯ãã«åºåã³ãããã®ç°æ§äœãæãããã
奜ãŸããã¯ç¡çœ®æã§ããããããã¯ïŒåãŸãã¯ïŒ
åã®ã¡ãã«ãŸãã¯ãšãã«åºã§çœ®æãããããã«ã
ãã³ãã«ãããã·ã«åºã§ããã äžè¬åŒïŒïŒã«ãããŠãå ·äœçã«å¥œãŸããR1
ãšããŠã¯ãããã«ããã³ãã«ãïŒâã¡ãã«ãã³ã
ã«ãïŒâã¡ãã«ãã³ãã«ãïŒâã¡ãã«ãã³ãã«ã
ïŒïŒïŒâãžã¡ãã«ãã³ãã«ãïŒâãšãã«ãã³ã
ã«ãïŒâãšãã«ãã³ãã«ãããã·ã«ãïŒâã¡ãã«
ããã·ã«ãïŒâã¡ãã«ããã·ã«ãïŒâãšãã«ãã
ã·ã«ãïŒâãšãã«ããã·ã«ããããã«ãïŒâã¡ã
ã«ãããã«åºãæããããç¹ã«å¥œãŸããã®ã¯ïœâ
ãã³ãã«åºã§ããã ããã«äžè¬åŒïŒïŒã«ãããŠã15äœã®ççŽ åå
ã«ã€ããŠããæ°Žé žåºã®å¥œãŸããé 眮ã¯Î±âé 眮ã§
ããã æ¬çºæã«å«ãŸããååç©ã¯ãPGDã®èªå°äœãš
ããŠåœåããããšãã§ãããäŸãã°ãæ¬çºæåå
ç©ã®ä»£è¡šäŸã§ããåŒ åã³ ã§ç€ºãããååç©ã¯ããããPGD2ã¢ã«ã³ãŒã«å
ã³ïŒâããªãã·âÎ9âPGD2ã¢ã«ã³ãŒã«ãšåœåã
ãããããã«æ¬çºæååç©ã¯ãäžèšåŒ ã§ç€ºãããããã¹ã¿ã³ïŒprostaneïŒã®èªå°äœãšã
ãŠçµç¹çã«åœåããããšãã§ããããã®å Žåãäž
èšïŒåã³ïŒã§ç€ºãããååç©ã¯ããããïŒ5ZïŒ
13EïŒâïŒ9SïŒ15SïŒâ11âãªããœããã¹ã¿âïŒïŒ13
âãžãšã³âïŒïŒïŒïŒ15âããªãªãŒã«åã³ïŒ5ZïŒ
13EïŒâïŒ15SïŒâ11âãªããœããã¹ã¿âïŒïŒïŒïŒ13
âããªãšã³âïŒïŒ15âãžãªãŒã«ãšåœåãããã æ¬çºæã«åŸãã°ãäžè¬åŒïŒïŒã§ç€ºãããæ¬çº
æååç©ã¯ãäžè¬åŒ ãŸã㯠ãåŒäžãR2ã¯çœ®æãããŠããªãããŸãã¯å°ãªã
ãšãïŒåã®ã¢ã«ãã«åºã§çœ®æãããŠããããã©ã
ãããã©ã³âïŒâã€ã«åºãŸãã¯ããã©ããããã©
ã³âïŒâã€ã«åºãããã¯ïŒâãšããã·ãšãã«åºã
奜ãŸããã¯ããã©ããããã©ã³âïŒâã€ã«åºãè¡š
ããããã®ä»ã®èšå·ã¯åèšãšåãæå³ãè¡šãããã ã§ç€ºãããååç©ã®ïŒäœãïŒäœåã³15äœããŸãã¯
ïŒäœåã³15äœã®OR2ãæ°Žé žåºã«ãé žæ§æ¡ä»¶äžã§å
æ°Žå解ããããšã«ãã補é ãããããã®å æ°Žå解
ã¯ã (1) é ¢é žãããããªã³é žãã·ãŠãŠé žãïœâãã«ãš
ã³ã¹ã«ãã³é žã®åŠãææ©é žã®æ°Žæº¶æ¶²åã¯å¡©é žã
ç¡«é žããªã³é žã®åŠãç¡æ©é žã®æ°Žæº¶æ¶²äžã奜é©ã«
ã¯æ°Žãšæ··åãããææ©æº¶åªãäŸãã°ã¡ã¿ããŒã«
åã¯ãšã¿ããŒã«ã®åŠãäœçŽã¢ã«ã«ããŒã«ïŒå¥œãŸ
ããã¯ã¡ã¿ããŒã«ïŒãåã¯ïŒïŒïŒâãžã¡ããã·
ãšã¿ã³ããžãªããµã³ãããã¯ããã©ããããã©
ã³ã®åŠããšãŒãã«ïŒå¥œãŸããã¯ããã©ãããã
ã©ã³ïŒã®ååšäžã«å®€æž©ãã75âã®æž©åºŠïŒå¥œãŸã
ãã¯45â以äžã®æž©åºŠïŒã§ãå㯠(2) ã¡ã¿ããŒã«åã¯ãšã¿ããŒã«ã®åŠãç¡æ°ŽäœçŽã¢
ã«ã«ããŒã«äžïœâãã«ãšã³ã¹ã«ãã³é žåã¯ããª
ãã«ãªãé ¢é žã®åŠãææ©é žã®ååšäž10ã45âã®
枩床ã§è¡ãªããããå æ°Žå解ã¯ã奜ãŸããã¯åž
å¡©é žåã³ããã©ããããã©ã³ã®æ··å液ãåžå¡©é ž
åã³ã¡ã¿ããŒã«ã®æ··å液ãé ¢é žãæ°Žåã³ããã©
ããããã©ã³ã®æ··å液ããªã³é žãæ°Žåã³ããã©
ããããã©ã³ã®æ··å液ãåã¯ïœâãã«ãšã³ã¹ã«
ãã³é žåã³ç¡æ°Žã¡ã¿ããŒã«ã®æ··å液ãçšããŠè¡
ãªãããã äžè¬åŒïŒïŒåã³ïŒïŒã§ç€ºãããååç©ã¯ã
次ã®å³åŒïŒ¡ã§ç€ºãããäžé£ã®åå¿å·¥çšã«ãã€ãŠè£œ
é ããããšãã§ãããå³åŒäžãR3ã¯ããªã¡ãã«
ã·ãªã«åºãããªãšãã«ã·ãªã«åºãããªããã«ã·ãª
ã«åºãtertâããã«ãžã¡ãã«ã·ãªã«åºãããªãã³
ãžã«ã·ãªã«åºãããªããšãã«ã·ãªã«åºã®åŠãäžçœ®
æã·ãªã«åºã奜ãŸããã¯tertâããã«ãžã¡ãã«ã·
ãªã«åºãè¡šãããã¯ã¢ã«ãã«ã¹ã«ããã«åºãã
ãã¯çœ®æãŸãã¯ç¡çœ®æã®ã¢ãªãŒã«ã¹ã«ããã«åºã
奜ãŸããã¯ã¡ã·ã«åºãŸãã¯ãã·ã«åºãè¡šãããã
ã®ä»ã®èšå·ã¯åèšãšåãæå³ãè¡šããã å³åŒïŒ¡äžã®åå·¥çšã¯ãã¹ãŠå ¬ç¥ã®åå¿ã«ã«ãã
è¡ãªãããããç°¡åã«èª¬æãããšãäŸãã°å·¥çš
ãïœãã¯æ°Žé žåºãä¿è·ããåå¿ã§ãããäžæŽ»æ§æ
æ©æº¶åªãäŸãã°å¡©åã¡ãã¬ã³ãã¯ãããã«ã ããž
ãšãã«ãšãŒãã«äžãçž®åå€ãäŸãã°ïœâãã«ãšã³
ã¹ã«ãã³é žãç¡«é žãããªãã«ãªãé ¢é žã®ååšäžã
ïŒïŒïŒâãžããããã©ã³ãïŒïŒïŒâãžããããã©
ã³ããšãã«ããã«ãšãŒãã«çãçšããŠå®€æž©ããâ
30âã®æž©åºŠã§è¡ãªãããã奜é©ã«ã¯å¡©åã¡ãã¬ã³
äžãããªãžã³ã®ïœâãã«ãšã³ã¹ã«ãã³é žå¡©ãŸãã¯
ïœâãã«ãšã³ã¹ã«ãã³é žã®ååšäžãïŒïŒïŒâãžã
ãããã©ã³ãçšããŠå®€æž©ã§è¡ãªãããã å·¥çšãïœãã¯OR3åºãæ°Žé žåºã«å€æããåå¿ã§
ããããã®åå¿ã«ã€ããŠã¯ãJohn WileyïŒ
SonsïŒInc瀟ïŒç±³åœïŒçºè¡ãâProtective Groups
in Organic SynthesisâïŒ39ã50ããŒãžïŒ1981ïŒ
ïŒä»¥åŸãæç®ïŒ¡ãšç¥èšãããïŒã«è©³ããèšèŒãããŠ
ãããã奜ãŸããã¯ããã©ããããã©ã³äžã宀枩
ã§ããã©ããã«ã¢ã³ã¢ããŠã ãããªãïŒïœâ
Bu4N+F-ïŒãçšããŠè¡ãªãããã å·¥çšãïœãã¯æ°Žé žåºããªããœåºã«å€æããããŸ
ãã¯åæã«OTåºãè±é¢ããC9âC10éã«äºéçµ
åã圢æããåå¿ã§ããããã®ãããªé žååå¿ã¯
ããç¥ãããŠãããäŸãã°ã (a) åæ±å çºè¡äºè°·å²æ²»ç·šèãææ©åæååŠå
æç·šïŒã176ã206ããŒãžïŒæå51幎ïŒæïŒæ¥ïŒã
å㯠(b) John WileyïŒSonsïŒIncïŒç€ŸïŒç±³åœïŒçºè¡
ãCompendium of Organic Synthetic Me
thodsã第ïŒå·»ïŒ191幎ïŒã第ïŒå·»ïŒ1974幎ïŒã第
ïŒå·»ïŒ1977幎ïŒã®ã»ã¯ã·ãšã³48åã¯168ã«è©³ã
ãèšèŒãããŠãããç¹ã«å¥œãŸããç·©åãªäžæ§æ¡
件äžã§ã®é žåã¯ãäŸãã°ãžã¡ãã«ã¹ã«ãã€ãâ
âã¯ããã¹ã¯ã·ã³ã€ããé¯äœãããªã¢ããœãŒ
ã«ââã¯ããã¹ã¯ã·ã³ã€ããé¯äœããžã¡ãã«
ã¹ã«ãã€ãé¯äœããžã¡ãã«ã¹ã«ãã€ãâå¡©çŽ é¯
äœãããªã¢ããœãŒã«âå¡©çŽ é¯äœã以äžãJ.
Amer.Chem.Soc.ïŒ94ïŒ7586ïŒ1972ïŒåç §ãããž
ã·ã¯ãããã·ã«ã«ã«ããžã€ããâãžã¡ãã«ã¹ã«
ããã·ãé¯äœãJ.Amer.Chem.Soc.ïŒ87ïŒ5661
ïŒ1965ïŒåç §ããããªãžããŠã ã¯ããã¯ãããŒã
ïŒC5H5NHCrO3ClïŒãTetrahedron LettersïŒ
2647ïŒ1975ïŒåç §ããç¡æ°Žç¡«é žâããªãžã³é¯äœ
ãJ.Amer.Chem.Soc.ïŒ89ïŒ5505ïŒ1967ïŒåç §ãã
å¡©åã¯ããã«ãJ.Amer.Chem.Soc.ïŒ97ïŒ5929
ïŒ1975ïŒåç §ããäžé žåã¯ãã âããªãžã³é¯äœ
ïŒäŸãã°ã³ãªã³ãºè©Šè¬ïŒããžãšãŒã³ãºè©Šè¬åã¯ã¯
ãã é žæº¶æ¶²ïŒäžé žåã¯ãã ãç¡«é žãã³ã¬ã³ãç¡«
é žåã³æ°Žãã補é ïŒãã·ãŠãŠé žã¯ãã©ã€ããšãž
ã¡ãã«ã¹ã«ããã·ããã¹ã¯ã³ïŒSwernïŒé žåã
çãçšããŠè¡ãªãããã奜é©ãªã®ã¯ã³ãªã³ãºé ž
åããžãšãŒã³ãºé žåãŸãã¯ã¹ã¯ã³é žåã§ããã
ã³ãªã³ãºé žåã¯ã¯ãããã«ã ãå¡©åã¡ãã¬ã³ã
åå¡©åççŽ ã®åŠãããã²ã³åçåæ°ŽçŽ äžå®€æž©ã
ãïŒâã®æž©åºŠã§è¡ãªãããããžãšãŒã³ãºé žåã¯
é垞宀枩以äžã®æž©åºŠã§è¡ãªããããã¹ã¯ã³é žå
ã¯ã¯ãããã«ã ãå¡©åã¡ãã¬ã³ã®åŠãããã²ã³
åçåæ°ŽçŽ äžâ50âãâ60âã§åå¿ããã次ã
ã§ããªãšãã«ã¢ãã³ã§åŠçããããšã«ããè¡ãª
ãããã å³åŒïŒ¡ã®åºçºåæã§ããäžè¬åŒïŒïŒåã³
ïŒïŒã§ç€ºãããååç©ã¯ã次ã®å³åŒïŒ¢ã«ç€ºãã
ãäžé£ã®åå¿å·¥çšã«ãã€ãŠè£œé ããããšãã§ã
ããå³åŒäžããã¹ãŠã®èšå·ã¯åèšãšåãæå³ãè¡š
ããã å³åŒïŒ¢äžã®åå·¥çšã¯ãã¹ãŠå ¬ç¥ã®åå¿ã«ããè¡
ãªãããããç°¡åã«èª¬æãããšãäŸãã°å·¥çš
ãïœãã¯11äœã®æ°Žé žåºãéžæçã«OR3åºã«å€æã
ãåå¿ã§ããããã®åå¿ã¯æç®ïŒ¡ã«è©³ããèšèŒã
ããŠãããã奜ãŸããã¯ãžã¡ãã«ã¢ããããªãž
ã³ããžã¡ãã«ãã«ã ã¢ããäžãããªãžã³ãã€ãã
ãŸãŒã«ãããªã¡ãã«ã¢ãã³ã®ãããªå¡©åºã®ååš
äžã宀枩ã50âã®æž©åºŠã§åŒClâR3ïŒåŒäžãR3ã¯å
èšãšåãæå³ãè¡šãããïŒã§ç€ºãããã¯ããã·ã©
ã³ååç©ãšåå¿ãããããšã«ããè¡ãªããããã
ã®å ŽåïŒäœã®æ°Žé žåºãåæã«ORåºã«å€æãããª
ãããã«æ³šææ·±ãè¡ãªãå¿ èŠãããã å·¥çšãïœ ãã¯ïŒäœã®æ°Žé žåºãOR2åºã«å€æãã
åå¿ã§ãããåèšããå·¥çšãïœããšåæ§ã«ããŠè¡
ãªãããšãã§ããã å·¥çšãïœãã¯ïŒäœã®æ°Žé žåºãOTåºã«å€æãã
åå¿ã§ããã(i)ããªãžã³ãŸãã¯ããªãšãã«ã¢ãã³
ã®ãããªäžçŽã¢ãã³ã®ååšäžãå¡©åã¡ãã¬ã³ã®ã
ããªäžæŽ»æ§ææ©æº¶åªäžããããã¯(ii)ããªãžã³äžã
â30âãã50âã®æž©åºŠã§ã¡ã·ã«ã¯ããªãã®ãããª
ã¢ã«ãã«ã¹ã«ããã«ã¯ããªããŸãã¯ãã·ã¯ã«ã¯ã
ãªãã®ãããªã¢ãªã«ã¹ã«ããã«ã¯ããªããšåå¿ã
ããããšã«ããè¡ãªãããã å·¥çšãïœãã¯âCOOCH3åºãCH2OHåºã«éå
ããåå¿ã§ããããã®ããã«çšããããéå å€ã§
ããã°ãããªããã®ã§ããããã奜ãŸããã¯ãã
ãµã³ãããã©ããããã©ã³ããã«ãšã³ã®ãããªäž
掻æ§ææ©æº¶åªäžãïŒâãâ30âã®æž©åºŠã§ãžã€ãœã
ãã«ã¢ã«ãããŠã ãã€ãã©ã€ãïŒDIBALïŒãçš
ããããšã«ããè¡ãªãããã äžè¬åŒïŒïŒã§ç€ºãããååç©ã¯ãããèªèº«å ¬
ç¥ã®ååç©ã§ãããç¹éæ59â1463å·æ现æžäžã«
äžè¬åŒïŒïŒã§ç€ºãããååç©ãšããŠé瀺ã
ããŠããã äžè¬åŒïŒïŒã§ç€ºãããããã¹ã¿ã°ã©ã³ãžã³ïŒ€
é¡äŒŒååç©ã®ã·ã¯ãããã¹ããªã³å æ¥ååç©ã¯ã
αâãβâãããã¯Î³âã·ã¯ãããã¹ããªã³ãã
ãã¯ãããã®æ··åç©ãçšããŠæ¥æ¬ç¹èš±ç¬¬790979å·
åã³ç¹éæ47â39057å·æ现æžèšèŒã®æ¹æ³ãçšã
ãããšã«ããåŸããããã·ã¯ãããã¹ããªã³å æ¥
ååç©ã«å€æããããšã«ããäžè¬åŒïŒïŒã§ç€ºã
ããããã¹ã¿ã°ã©ã³ãžã³ïŒ€é¡äŒŒååç©ã®å®å®æ§ã
å¢å€§ããã äžè¬åŒïŒïŒã§ç€ºãããããã¹ã¿ã°ã©ã³ãžã³ïŒ€
é¡äŒŒååç©ãåã³ãããã®ã·ã¯ãããã¹ããªã³å
æ¥ååç©ãæè «çå€ãšããŠçšããã«ã¯ãéåžžå šèº«
çãããã¯å±æçã«ãçµå£ãŸãã¯éçµå£ã§æäžã
ãããæäžéã¯å¹Žä»€ãäœéãçç¶ãæ²»çå¹æãæ
äžæ¹æ³ãåŠçæéçã«ããç°ãªãããéåžžæ人ã²
ãšãåœããïŒåã«ã€ãïŒmgã500mgã®ç¯å²ã§ïŒæ¥
ïŒåããæ°åæäžãããããŸãã¯æ人ã²ãšãåœ
ããïŒåã«ã€ã500ÎŒïœã50mgã®ç¯å²ã§ïŒæ¥ïŒå
ããæ°åéçµå£æäžã奜ãŸããã¯éèå æäžãã
ãããã¡ããåèšããããã«ãæäžéã¯çš®ã ã®æ¡
件ã§å€åããã®ã§ãäžèšæäžéç¯å²ããå°ãªãé
ã§ååãªå ŽåããããããŸãç¯å²ãè¶ããŠå¿ èŠãª
å Žåãããã æ¬çºæã«ããçµå£æäžã®ããã®åºäœçµæç©ãšã
ãŠã¯ãé å€ãæ£å€ãé¡ç²å€çãå«ãŸããããã®ã
ããªåºäœçµæç©ã«ãããŠã¯ãã²ãšã€ãŸãã¯ãã以
äžã®æŽ»æ§ç©è³ªããå°ãªããšãã²ãšã€ã®äžæŽ»æ§ãªåž
éå€ãäŸãã°ä¹³ç³ããã³ãããŒã«ããããŠç³ãã
ãããã·ãããã«ã»ã«ããŒã¹ã埮çµæ¶ã»ã«ããŒ
ã¹ããã³ãã³ãããªããã«ãããªãã³ãã¡ã¿ã±ã€
é žã¢ã«ãã³é žãã°ãã·ãŠã ãšæ··åããããçµæç©
ã¯ãåžžæ³ã«åŸã€ãŠãäžæŽ»æ§ãªåžéå€ä»¥å€ã®æ·»å
å€ãäŸãã°ã¹ãã¢ãªã³é žãã°ãã·ãŠã ã®ãããªæœ€
æ»å€ãç¹ç¶çŽ ã°ã«ã³ã³é žã«ã«ã·ãŠã ã®ãããªåŽ©å£
å€ãå«æããŠããŠããããé å€ãŸãã¯äžžå€ã¯å¿ èŠ
ã«ããçœç³ããŒã©ãã³ãããããã·ãããã«ã»ã«
ããŒã¹ãããããã·ãããã«ã¡ãã«ã»ã«ããŒã¹ã
ã¿ã¬ãŒããªã©ã®è溶æ§ãããã¯è žæº¶æ§ç©è³ªã®ãã€
ã«ã ã§è¢«èããŠããããããŸãïŒä»¥äžã®å±€ã§è¢«è
ããŠããããããã«ãŒã©ãã³ã®ãããªåžåããã
ãç©è³ªã®ã«ãã»ã«å€ãšããŠãããã çµå£æäžã®ããã®æ¶²äœçµæç©ã¯ãè¬å€çã«èš±å®¹
ãããä¹³æ¿å€ã溶液å€ãæžæ¿å€ãã·ãããå€ããš
ãªãã·ã«å€çãå«ã¿ãäžè¬çã«çšããããäžæŽ»æ§
ãªåžéå€ãäŸãã°ç²Ÿè£œæ°Žããšã¿ããŒã«ãå«ããã
ã®çµæç©ãªäžæŽ»æ§ãªåžéå€ä»¥å€ã«æ¹¿æœ€å€ãæžæ¿å€
ã®ãããªè£å©å€ãçå³å€ã颚å³å€ãè³éŠå€ãé²è
å€ãå«æããŠããŠãããã çµå£æäžã®ãããã®ä»ã®çµæç©ãšããŠã¯ãã²ãš
ã€ãŸãã¯ãã以äžã®æŽ»æ§ç©è³ªãå«ã¿ãããèªäœå ¬
ç¥ã®æ¹æ³ã«ããåŠæ¹ãããã¹ãã¬ãŒå€ãå«ãŸã
ãã æ¬çºæã«ããéçµå£æäžã®ããã®æ³šå°å€ãšããŠ
ã¯ãç¡èã®æ°Žæ§ãŸãã¯éæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ã
ä¹³æ¿å€ãå å«ãããæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ãšããŠ
ã¯äŸãã°æ³šå°çšèžçæ°Žåã³ççé£å¡©æ°Žãå«ãŸã
ããéæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ãšããŠã¯ãäŸãã°ã
ããã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ã
ãªãªãŒãæ²¹ã®ãããªæ€ç©æ²¹ãã¡ã¿ããŒã«ã®ãããª
ã¢ã«ã³ãŒã«é¡ãããªãœã«ããŒã80çãããããã®
ãããªçµæç©ã¯ãããã«é²è å€ã湿最å€ãä¹³å
å€ãåæ£å€ã®ãããªè£å©å€ãå«ãã§ãããããã
ãã¯äŸãã°ãã¯ããªã¢ä¿çãã€ã«ã¿ãŒãéã
éã殺èå€ã®é åãŸãã¯ç §å°ã«ãã€ãŠç¡èåãã
ãããããã¯ãŸãç¡èã®åºäœçµæç©ã補é ãã䜿
çšåã«ç¡èæ°ŽãŸãã¯ç¡èã®æ³šå°çšæº¶åªã«æº¶è§£ããŠ
䜿çšããããšãã§ããã éçµå£æäžã®ããã®ãã®ä»ã®çµæç©ãšããŠã¯ã
ã²ãšã€ãŸãã¯ãã以äžã®æŽ»æ§ç©è³ªãå«ã¿ãããèª
äœå ¬ç¥ã®æ¹æ³ã«ããåŠæ¹ãããå€çšæ¶²å€ãè»ã³ãŠ
ã®ãããªå¡åžå€ãçŽè žå æäžã®ããã®åå€åã³è£
å æäžã®ããã®ãããµãªãŒçãå«ãŸããã æ¬çºæã«å«ãŸããäžè¬åŒïŒïŒ¡ïŒãŸãã¯ïŒ
ïŒã§ç€ºãããååç©ã®ãã¡ã奜ãŸãããã®ãšã
ãŠã¯ãäŸãã° 20âãã«âPGD2ã¢ã«ã³ãŒã«ã PGD2ã¢ã«ã³ãŒã«ã 16âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 17âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 18âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 16ïŒ16âãžã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 16âãšãã«âPGD2ã¢ã«ã³ãŒã«ã 17âãšãã«âPGD2ã¢ã«ã³ãŒã«ã 20âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 16ïŒ20âãžã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 17ïŒ20âãžã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 16âãšãã«â20âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 17âãšãã«â20âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ãã 20âãšãã«âPGD2ã¢ã«ã³ãŒã«ã 17âã¡ãã«â20âãšãã«âPGD2ã¢ã«ã³ãŒã«ã 17ïŒ20âãžãšãã«âPGD2ã¢ã«ã³ãŒã«ã 20âãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³ãŒ
ã«ã ïŒâããªãã·âÎ9âPGD2ã¢ã«ã³ãŒã«ã 16âã¡ãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 17âã¡ãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 18âã¡ãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 16ïŒ16âãžã¡ãã«âïŒâããªãã·âÎ9âPGD2
ã¢ã«ã³ãŒã«ã 16âãšãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 17âãšãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 20âã¡ãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 16ïŒ20âãžã¡ãã«âïŒâããªãã·âÎ9âPGD2
ã¢ã«ã³ãŒã«ã 17ïŒ20âãžã¡ãã«âïŒâããªãã·âÎ9âPGD2
ã¢ã«ã³ãŒã«ã 16âãšãã«â20âã¡ãã«âïŒâããªãã·âÎ9
âPGD2ã¢ã«ã³ãŒã«ã 17âãšãã«â20âã¡ãã«âïŒâããªãã·âÎ9
âPGD2ã¢ã«ã³ãŒã«ã 20âãšãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 17âã¡ãã«â20âãšãã«âïŒâããªãã·âÎ9
âPGD2ã¢ã«ã³ãŒã«ã 17ïŒ20âãžãšãã«âïŒâããªãã·âÎ9âPGD2
ã¢ã«ã³ãŒã«ã ãæããããã 以äžãåèäŸåã³å®æœäŸã«ããæ¬çºæã詳述ã
ãããæ¬çºæã¯ãããã®å®æœäŸã«éå®ããããã®
ã§ã¯ãªãããªãåèäŸåã³å®æœäŸäžã®ãTLCãã
ãNMRãããIRãåã³ãMassãã¯ãåã ãèå±€ã¯
ãããã°ã©ãã€ããæ žç£æ°å ±é³Žã¹ãã¯ãã«ãããèµ€
å€åžåã¹ãã¯ãã«ãåã³ã質éåæããè¡šããã
ãŸãæ§é åŒäžã®BMSãTHPåã³Msã¯ãåã tert
âããã«ãžã¡ãã«ã·ãªã«åºãããã©ããããã©ã³
âïŒâã€ã«åºåã³ã¡ã·ã«åºïŒã¡ã¿ã³ã¹ã«ããã«
åºïŒãè¡šãããã¯ãããã°ã©ãã€ã«ããåé¢ã®ç®
æã«èšèŒãããŠããã«ãã³å ã®æº¶åªã¯äœ¿çšãã溶
åºæº¶åªãŸãã¯å±é溶åªã瀺ããç¹å¥ã®èšèŒããªã
å Žåã«ã¯ãIRã¯æ¶²èæ³ã§æž¬å®ããNMRã¯éã¯ã
ããã«ã ïŒCDCl3ïŒæº¶æ¶²ã§æž¬å®ããŠããã åèäŸ ïŒ ã®åæ 也ç¥ããªãžã³55mlã«æº¶ãããïŒ5ZïŒ13EïŒâ
ïŒ9αïŒ11αïŒ15SïŒâïŒïŒ11âãžããããã·â15â
ïŒããã©ããããã©ã³âïŒâã€ã«ãªãã·ïŒããã¹
ã¿ãŒïŒïŒ13âãžãšã³é žã¡ãã«ãšã¹ãã«ç¹éæ59â
1463å·æ现æžåèäŸïŒèšèŒã®ååç©ïŒïŒïœã«ããž
ã¡ãã«ã¢ããããªãžã³134mgåã³tertâããã«ãž
ã¡ãã«ã¯ããã·ã©ã³8.33ïœãå ãã35âã§ïŒæé
ãããŸãããåå¿æ··åç©ã«ãžãšãã«ãšãŒãã«500
mlãå ããåŸãæ°Žãå·ïŒèŠå®å¡©é žãæ°Žåã³é£œåé£
å¡©æ°Žã§é 次æŽæµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥
åŸæžå§æ¿çž®ãããæ®çç©ãã·ãªã«ã²ã«ã«ã©ã ã¯ã
ããã°ã©ãã€ïŒïœâãããµã³ãšé ¢é žãšãã«ã®æ··å
液ã次ãã§é ¢é žãšãã«ã®ã¿ïŒã§ç²Ÿè£œããŠã次ã®ç©
æ§å€ãæããæšé¡ååç©6.6ïœïŒäžéšäžçŽç©ãå«
ãïŒãåŸãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒRf
ïŒ0.74ïŒ NMRïŒÎŽïŒ5.5ã5.1ïŒ4HïŒïœïŒã4.7ã4.5ïŒ1HïŒ
ïœïŒã4.3ã3.2ïŒ5HïŒïœïŒã3.6ïŒ3HïŒïœïŒã0.9
ïŒ9HïŒïœïŒã1.0ã0.8ïŒ3HïŒïœïŒïŒ IRïŒÎœïŒ3500ã2930ã1735ã1250ã1015ã975cm
-1ïŒ MassïŒïœïŒïœ ïŒ509ã407ã åèäŸ ïŒ ã®åæ å¡©åã¡ãã¬ã³56mlã«æº¶ãããïŒâããããã·äœ
ïŒåèäŸïŒã§è£œé ãããïŒ6.6ïœã«ã宀枩ã§ïŒïŒïŒ
âãžããããã©ã³3.16mlåã³ïœâãã«ãšã³ã¹ã«ã
ã³é žïŒæ°Žåç©68.5mgãå ããå枩床ã§ïŒæéãã
ãŸãããåå¿æ··åç©ã«ããªãšãã«ã¢ãã³ãå ããŠ
PHïŒã«èª¿æŽããåŸããžãšãã«ãšãŒãã«300mlãå
ããæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽæµããç¡æ°Žç¡«é žã
ã°ãã·ãŠã ã§ä¹Ÿç¥æžå§æ¿çž®ãããæ®çç©ãã·ãªã«
ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ïŒïœâãããµã³ã次
ãã§ïœâãããµã³ãšé ¢é žãšãã«ã®æ··å液ïŒã§ç²Ÿè£œ
ããŠã次ã®ç©æ§å€ãæããæšé¡ååç©6.3ïœãåŸ
ãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒRf
ïŒ0.40ïŒ NMRïŒÎŽïŒ5.6ã5.0ïŒ4HïŒïœïŒã4.7ã4.4ïŒ2HïŒ
ïœïŒã4.3ã3.1ïŒ7HïŒïœïŒã3.6ïŒ3HïŒïœïŒã0.9
ïŒ12HïŒïœåã³ïœïŒïŒ IRïŒÎœïŒ2920ã2850ã1740ã1450ã1250ã1120ã
1020ã985cm-1ïŒ MassïŒïœïŒïœ ïŒ598ã548ã509ã491ã åèäŸ ïŒ ã®åæ å¡©åã¡ãã¬ã³60mlã«æº¶ãããïŒâããããã·äœ
ïŒåèäŸïŒã§è£œé ãããïŒ7.13ïœã«ãããªãšãã«ã¢
ãã³6.6mlãâ30âã§å ããããã«ã¡ã·ã«ã¯ãã©
ã€ã3.1mlã滎äžããå枩床ã§40åéã次ãã§ïŒ
âã§20åéãããŸãããåå¿æ··åç©ã«æ°Ž50mlåã³
å¡©åã¡ãã¬ã³150mlãå ããŠãå¡©åã¡ãã¬ã³å±€ã
飜åé£å¡©æ°Žã§æŽæµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿ
ç¥åŸæžå§æ¿çž®ãããæ®çç©ãã·ãªã«ã²ã«ã«ã©ã ã¯
ãããã°ã©ãã€ïŒé ¢é žãšãã«ãšïœâãããµã³ã®æ··
å液ïŒã§ç²Ÿè£œãã次ã®ç©æ§å€ãæããæšé¡ååç©
6.93ïœãåŸãã TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.42ïŒ NMRïŒCCl4溶液ïŒïŒÎŽïŒ5.7ã5.2ïŒ4HïŒïœïŒã4.9
ïŒ1HïŒïœïŒã4.6ïŒ1HïŒïœïŒã3.6ïŒ3HïŒïœïŒã2.9
ïŒ3HïŒïœïŒã0.9ïŒ9HïŒïœïŒã0.1ïŒ6HïŒïœïŒïŒ IRïŒÎœïŒ2940ã1740ã1358ã1173ã912cm-1ïŒ åèäŸ ïŒ
äžæççŽ ãååšãããäŸãã°äžè¬åŒïŒïŒã«ãã
ãŠããããåŒïŒïŒã§ç€ºãããåºãè¡šããåå
ç©ã«ã¯ãïŒåã®äžæäžå¿ïŒããªãã¡ãïŒäœãïŒ
äœã12äœåã³15äœã®ççŽ ååïŒãååšãããã
ãåŒïŒïŒã§ç€ºãããåºãè¡šããååç©ã§ã¯ãïŒ
äœã12äœåã³15äœã®ççŽ ååãäžæççŽ ã§ããã
ããã«R1ãè¡šããã¢ã«ãã«åºãåæéã§ããå Ž
åã«ã¯ãä»ã®äžæççŽ ãçããå¯èœæ§ããããã
ãããªãããæ¬çºæã®äžè¬åŒïŒïŒã§ç€ºãããå
åç©ã¯ãäžæççŽ ã«ãã€ãŠãŠçããåã ã®ç°æ§äœ
åã³ãããã®æ··åç©ããå«æãããã®ã§ããã äžè¬åŒïŒïŒã«ãããŠãR1ãè¡šããççŽ æ°ïŒ
ãïŒã®ã¢ã«ãã«åºãšããŠã¯ãã¡ãã«ããšãã«ãã
ããã«ãããã«ããã³ãã«ãããã·ã«ãããã
ã«ããªã¯ãã«åºåã³ãããã®ç°æ§äœãæãããã
奜ãŸããã¯ç¡çœ®æã§ããããããã¯ïŒåãŸãã¯ïŒ
åã®ã¡ãã«ãŸãã¯ãšãã«åºã§çœ®æãããããã«ã
ãã³ãã«ãããã·ã«åºã§ããã äžè¬åŒïŒïŒã«ãããŠãå ·äœçã«å¥œãŸããR1
ãšããŠã¯ãããã«ããã³ãã«ãïŒâã¡ãã«ãã³ã
ã«ãïŒâã¡ãã«ãã³ãã«ãïŒâã¡ãã«ãã³ãã«ã
ïŒïŒïŒâãžã¡ãã«ãã³ãã«ãïŒâãšãã«ãã³ã
ã«ãïŒâãšãã«ãã³ãã«ãããã·ã«ãïŒâã¡ãã«
ããã·ã«ãïŒâã¡ãã«ããã·ã«ãïŒâãšãã«ãã
ã·ã«ãïŒâãšãã«ããã·ã«ããããã«ãïŒâã¡ã
ã«ãããã«åºãæããããç¹ã«å¥œãŸããã®ã¯ïœâ
ãã³ãã«åºã§ããã ããã«äžè¬åŒïŒïŒã«ãããŠã15äœã®ççŽ åå
ã«ã€ããŠããæ°Žé žåºã®å¥œãŸããé 眮ã¯Î±âé 眮ã§
ããã æ¬çºæã«å«ãŸããååç©ã¯ãPGDã®èªå°äœãš
ããŠåœåããããšãã§ãããäŸãã°ãæ¬çºæåå
ç©ã®ä»£è¡šäŸã§ããåŒ åã³ ã§ç€ºãããååç©ã¯ããããPGD2ã¢ã«ã³ãŒã«å
ã³ïŒâããªãã·âÎ9âPGD2ã¢ã«ã³ãŒã«ãšåœåã
ãããããã«æ¬çºæååç©ã¯ãäžèšåŒ ã§ç€ºãããããã¹ã¿ã³ïŒprostaneïŒã®èªå°äœãšã
ãŠçµç¹çã«åœåããããšãã§ããããã®å Žåãäž
èšïŒåã³ïŒã§ç€ºãããååç©ã¯ããããïŒ5ZïŒ
13EïŒâïŒ9SïŒ15SïŒâ11âãªããœããã¹ã¿âïŒïŒ13
âãžãšã³âïŒïŒïŒïŒ15âããªãªãŒã«åã³ïŒ5ZïŒ
13EïŒâïŒ15SïŒâ11âãªããœããã¹ã¿âïŒïŒïŒïŒ13
âããªãšã³âïŒïŒ15âãžãªãŒã«ãšåœåãããã æ¬çºæã«åŸãã°ãäžè¬åŒïŒïŒã§ç€ºãããæ¬çº
æååç©ã¯ãäžè¬åŒ ãŸã㯠ãåŒäžãR2ã¯çœ®æãããŠããªãããŸãã¯å°ãªã
ãšãïŒåã®ã¢ã«ãã«åºã§çœ®æãããŠããããã©ã
ãããã©ã³âïŒâã€ã«åºãŸãã¯ããã©ããããã©
ã³âïŒâã€ã«åºãããã¯ïŒâãšããã·ãšãã«åºã
奜ãŸããã¯ããã©ããããã©ã³âïŒâã€ã«åºãè¡š
ããããã®ä»ã®èšå·ã¯åèšãšåãæå³ãè¡šãããã ã§ç€ºãããååç©ã®ïŒäœãïŒäœåã³15äœããŸãã¯
ïŒäœåã³15äœã®OR2ãæ°Žé žåºã«ãé žæ§æ¡ä»¶äžã§å
æ°Žå解ããããšã«ãã補é ãããããã®å æ°Žå解
ã¯ã (1) é ¢é žãããããªã³é žãã·ãŠãŠé žãïœâãã«ãš
ã³ã¹ã«ãã³é žã®åŠãææ©é žã®æ°Žæº¶æ¶²åã¯å¡©é žã
ç¡«é žããªã³é žã®åŠãç¡æ©é žã®æ°Žæº¶æ¶²äžã奜é©ã«
ã¯æ°Žãšæ··åãããææ©æº¶åªãäŸãã°ã¡ã¿ããŒã«
åã¯ãšã¿ããŒã«ã®åŠãäœçŽã¢ã«ã«ããŒã«ïŒå¥œãŸ
ããã¯ã¡ã¿ããŒã«ïŒãåã¯ïŒïŒïŒâãžã¡ããã·
ãšã¿ã³ããžãªããµã³ãããã¯ããã©ããããã©
ã³ã®åŠããšãŒãã«ïŒå¥œãŸããã¯ããã©ãããã
ã©ã³ïŒã®ååšäžã«å®€æž©ãã75âã®æž©åºŠïŒå¥œãŸã
ãã¯45â以äžã®æž©åºŠïŒã§ãå㯠(2) ã¡ã¿ããŒã«åã¯ãšã¿ããŒã«ã®åŠãç¡æ°ŽäœçŽã¢
ã«ã«ããŒã«äžïœâãã«ãšã³ã¹ã«ãã³é žåã¯ããª
ãã«ãªãé ¢é žã®åŠãææ©é žã®ååšäž10ã45âã®
枩床ã§è¡ãªããããå æ°Žå解ã¯ã奜ãŸããã¯åž
å¡©é žåã³ããã©ããããã©ã³ã®æ··å液ãåžå¡©é ž
åã³ã¡ã¿ããŒã«ã®æ··å液ãé ¢é žãæ°Žåã³ããã©
ããããã©ã³ã®æ··å液ããªã³é žãæ°Žåã³ããã©
ããããã©ã³ã®æ··å液ãåã¯ïœâãã«ãšã³ã¹ã«
ãã³é žåã³ç¡æ°Žã¡ã¿ããŒã«ã®æ··å液ãçšããŠè¡
ãªãããã äžè¬åŒïŒïŒåã³ïŒïŒã§ç€ºãããååç©ã¯ã
次ã®å³åŒïŒ¡ã§ç€ºãããäžé£ã®åå¿å·¥çšã«ãã€ãŠè£œ
é ããããšãã§ãããå³åŒäžãR3ã¯ããªã¡ãã«
ã·ãªã«åºãããªãšãã«ã·ãªã«åºãããªããã«ã·ãª
ã«åºãtertâããã«ãžã¡ãã«ã·ãªã«åºãããªãã³
ãžã«ã·ãªã«åºãããªããšãã«ã·ãªã«åºã®åŠãäžçœ®
æã·ãªã«åºã奜ãŸããã¯tertâããã«ãžã¡ãã«ã·
ãªã«åºãè¡šãããã¯ã¢ã«ãã«ã¹ã«ããã«åºãã
ãã¯çœ®æãŸãã¯ç¡çœ®æã®ã¢ãªãŒã«ã¹ã«ããã«åºã
奜ãŸããã¯ã¡ã·ã«åºãŸãã¯ãã·ã«åºãè¡šãããã
ã®ä»ã®èšå·ã¯åèšãšåãæå³ãè¡šããã å³åŒïŒ¡äžã®åå·¥çšã¯ãã¹ãŠå ¬ç¥ã®åå¿ã«ã«ãã
è¡ãªãããããç°¡åã«èª¬æãããšãäŸãã°å·¥çš
ãïœãã¯æ°Žé žåºãä¿è·ããåå¿ã§ãããäžæŽ»æ§æ
æ©æº¶åªãäŸãã°å¡©åã¡ãã¬ã³ãã¯ãããã«ã ããž
ãšãã«ãšãŒãã«äžãçž®åå€ãäŸãã°ïœâãã«ãšã³
ã¹ã«ãã³é žãç¡«é žãããªãã«ãªãé ¢é žã®ååšäžã
ïŒïŒïŒâãžããããã©ã³ãïŒïŒïŒâãžããããã©
ã³ããšãã«ããã«ãšãŒãã«çãçšããŠå®€æž©ããâ
30âã®æž©åºŠã§è¡ãªãããã奜é©ã«ã¯å¡©åã¡ãã¬ã³
äžãããªãžã³ã®ïœâãã«ãšã³ã¹ã«ãã³é žå¡©ãŸãã¯
ïœâãã«ãšã³ã¹ã«ãã³é žã®ååšäžãïŒïŒïŒâãžã
ãããã©ã³ãçšããŠå®€æž©ã§è¡ãªãããã å·¥çšãïœãã¯OR3åºãæ°Žé žåºã«å€æããåå¿ã§
ããããã®åå¿ã«ã€ããŠã¯ãJohn WileyïŒ
SonsïŒInc瀟ïŒç±³åœïŒçºè¡ãâProtective Groups
in Organic SynthesisâïŒ39ã50ããŒãžïŒ1981ïŒ
ïŒä»¥åŸãæç®ïŒ¡ãšç¥èšãããïŒã«è©³ããèšèŒãããŠ
ãããã奜ãŸããã¯ããã©ããããã©ã³äžã宀枩
ã§ããã©ããã«ã¢ã³ã¢ããŠã ãããªãïŒïœâ
Bu4N+F-ïŒãçšããŠè¡ãªãããã å·¥çšãïœãã¯æ°Žé žåºããªããœåºã«å€æããããŸ
ãã¯åæã«OTåºãè±é¢ããC9âC10éã«äºéçµ
åã圢æããåå¿ã§ããããã®ãããªé žååå¿ã¯
ããç¥ãããŠãããäŸãã°ã (a) åæ±å çºè¡äºè°·å²æ²»ç·šèãææ©åæååŠå
æç·šïŒã176ã206ããŒãžïŒæå51幎ïŒæïŒæ¥ïŒã
å㯠(b) John WileyïŒSonsïŒIncïŒç€ŸïŒç±³åœïŒçºè¡
ãCompendium of Organic Synthetic Me
thodsã第ïŒå·»ïŒ191幎ïŒã第ïŒå·»ïŒ1974幎ïŒã第
ïŒå·»ïŒ1977幎ïŒã®ã»ã¯ã·ãšã³48åã¯168ã«è©³ã
ãèšèŒãããŠãããç¹ã«å¥œãŸããç·©åãªäžæ§æ¡
件äžã§ã®é žåã¯ãäŸãã°ãžã¡ãã«ã¹ã«ãã€ãâ
âã¯ããã¹ã¯ã·ã³ã€ããé¯äœãããªã¢ããœãŒ
ã«ââã¯ããã¹ã¯ã·ã³ã€ããé¯äœããžã¡ãã«
ã¹ã«ãã€ãé¯äœããžã¡ãã«ã¹ã«ãã€ãâå¡©çŽ é¯
äœãããªã¢ããœãŒã«âå¡©çŽ é¯äœã以äžãJ.
Amer.Chem.Soc.ïŒ94ïŒ7586ïŒ1972ïŒåç §ãããž
ã·ã¯ãããã·ã«ã«ã«ããžã€ããâãžã¡ãã«ã¹ã«
ããã·ãé¯äœãJ.Amer.Chem.Soc.ïŒ87ïŒ5661
ïŒ1965ïŒåç §ããããªãžããŠã ã¯ããã¯ãããŒã
ïŒC5H5NHCrO3ClïŒãTetrahedron LettersïŒ
2647ïŒ1975ïŒåç §ããç¡æ°Žç¡«é žâããªãžã³é¯äœ
ãJ.Amer.Chem.Soc.ïŒ89ïŒ5505ïŒ1967ïŒåç §ãã
å¡©åã¯ããã«ãJ.Amer.Chem.Soc.ïŒ97ïŒ5929
ïŒ1975ïŒåç §ããäžé žåã¯ãã âããªãžã³é¯äœ
ïŒäŸãã°ã³ãªã³ãºè©Šè¬ïŒããžãšãŒã³ãºè©Šè¬åã¯ã¯
ãã é žæº¶æ¶²ïŒäžé žåã¯ãã ãç¡«é žãã³ã¬ã³ãç¡«
é žåã³æ°Žãã補é ïŒãã·ãŠãŠé žã¯ãã©ã€ããšãž
ã¡ãã«ã¹ã«ããã·ããã¹ã¯ã³ïŒSwernïŒé žåã
çãçšããŠè¡ãªãããã奜é©ãªã®ã¯ã³ãªã³ãºé ž
åããžãšãŒã³ãºé žåãŸãã¯ã¹ã¯ã³é žåã§ããã
ã³ãªã³ãºé žåã¯ã¯ãããã«ã ãå¡©åã¡ãã¬ã³ã
åå¡©åççŽ ã®åŠãããã²ã³åçåæ°ŽçŽ äžå®€æž©ã
ãïŒâã®æž©åºŠã§è¡ãªãããããžãšãŒã³ãºé žåã¯
é垞宀枩以äžã®æž©åºŠã§è¡ãªããããã¹ã¯ã³é žå
ã¯ã¯ãããã«ã ãå¡©åã¡ãã¬ã³ã®åŠãããã²ã³
åçåæ°ŽçŽ äžâ50âãâ60âã§åå¿ããã次ã
ã§ããªãšãã«ã¢ãã³ã§åŠçããããšã«ããè¡ãª
ãããã å³åŒïŒ¡ã®åºçºåæã§ããäžè¬åŒïŒïŒåã³
ïŒïŒã§ç€ºãããååç©ã¯ã次ã®å³åŒïŒ¢ã«ç€ºãã
ãäžé£ã®åå¿å·¥çšã«ãã€ãŠè£œé ããããšãã§ã
ããå³åŒäžããã¹ãŠã®èšå·ã¯åèšãšåãæå³ãè¡š
ããã å³åŒïŒ¢äžã®åå·¥çšã¯ãã¹ãŠå ¬ç¥ã®åå¿ã«ããè¡
ãªãããããç°¡åã«èª¬æãããšãäŸãã°å·¥çš
ãïœãã¯11äœã®æ°Žé žåºãéžæçã«OR3åºã«å€æã
ãåå¿ã§ããããã®åå¿ã¯æç®ïŒ¡ã«è©³ããèšèŒã
ããŠãããã奜ãŸããã¯ãžã¡ãã«ã¢ããããªãž
ã³ããžã¡ãã«ãã«ã ã¢ããäžãããªãžã³ãã€ãã
ãŸãŒã«ãããªã¡ãã«ã¢ãã³ã®ãããªå¡©åºã®ååš
äžã宀枩ã50âã®æž©åºŠã§åŒClâR3ïŒåŒäžãR3ã¯å
èšãšåãæå³ãè¡šãããïŒã§ç€ºãããã¯ããã·ã©
ã³ååç©ãšåå¿ãããããšã«ããè¡ãªããããã
ã®å ŽåïŒäœã®æ°Žé žåºãåæã«ORåºã«å€æãããª
ãããã«æ³šææ·±ãè¡ãªãå¿ èŠãããã å·¥çšãïœ ãã¯ïŒäœã®æ°Žé žåºãOR2åºã«å€æãã
åå¿ã§ãããåèšããå·¥çšãïœããšåæ§ã«ããŠè¡
ãªãããšãã§ããã å·¥çšãïœãã¯ïŒäœã®æ°Žé žåºãOTåºã«å€æãã
åå¿ã§ããã(i)ããªãžã³ãŸãã¯ããªãšãã«ã¢ãã³
ã®ãããªäžçŽã¢ãã³ã®ååšäžãå¡©åã¡ãã¬ã³ã®ã
ããªäžæŽ»æ§ææ©æº¶åªäžããããã¯(ii)ããªãžã³äžã
â30âãã50âã®æž©åºŠã§ã¡ã·ã«ã¯ããªãã®ãããª
ã¢ã«ãã«ã¹ã«ããã«ã¯ããªããŸãã¯ãã·ã¯ã«ã¯ã
ãªãã®ãããªã¢ãªã«ã¹ã«ããã«ã¯ããªããšåå¿ã
ããããšã«ããè¡ãªãããã å·¥çšãïœãã¯âCOOCH3åºãCH2OHåºã«éå
ããåå¿ã§ããããã®ããã«çšããããéå å€ã§
ããã°ãããªããã®ã§ããããã奜ãŸããã¯ãã
ãµã³ãããã©ããããã©ã³ããã«ãšã³ã®ãããªäž
掻æ§ææ©æº¶åªäžãïŒâãâ30âã®æž©åºŠã§ãžã€ãœã
ãã«ã¢ã«ãããŠã ãã€ãã©ã€ãïŒDIBALïŒãçš
ããããšã«ããè¡ãªãããã äžè¬åŒïŒïŒã§ç€ºãããååç©ã¯ãããèªèº«å ¬
ç¥ã®ååç©ã§ãããç¹éæ59â1463å·æ现æžäžã«
äžè¬åŒïŒïŒã§ç€ºãããååç©ãšããŠé瀺ã
ããŠããã äžè¬åŒïŒïŒã§ç€ºãããããã¹ã¿ã°ã©ã³ãžã³ïŒ€
é¡äŒŒååç©ã®ã·ã¯ãããã¹ããªã³å æ¥ååç©ã¯ã
αâãβâãããã¯Î³âã·ã¯ãããã¹ããªã³ãã
ãã¯ãããã®æ··åç©ãçšããŠæ¥æ¬ç¹èš±ç¬¬790979å·
åã³ç¹éæ47â39057å·æ现æžèšèŒã®æ¹æ³ãçšã
ãããšã«ããåŸããããã·ã¯ãããã¹ããªã³å æ¥
ååç©ã«å€æããããšã«ããäžè¬åŒïŒïŒã§ç€ºã
ããããã¹ã¿ã°ã©ã³ãžã³ïŒ€é¡äŒŒååç©ã®å®å®æ§ã
å¢å€§ããã äžè¬åŒïŒïŒã§ç€ºãããããã¹ã¿ã°ã©ã³ãžã³ïŒ€
é¡äŒŒååç©ãåã³ãããã®ã·ã¯ãããã¹ããªã³å
æ¥ååç©ãæè «çå€ãšããŠçšããã«ã¯ãéåžžå šèº«
çãããã¯å±æçã«ãçµå£ãŸãã¯éçµå£ã§æäžã
ãããæäžéã¯å¹Žä»€ãäœéãçç¶ãæ²»çå¹æãæ
äžæ¹æ³ãåŠçæéçã«ããç°ãªãããéåžžæ人ã²
ãšãåœããïŒåã«ã€ãïŒmgã500mgã®ç¯å²ã§ïŒæ¥
ïŒåããæ°åæäžãããããŸãã¯æ人ã²ãšãåœ
ããïŒåã«ã€ã500ÎŒïœã50mgã®ç¯å²ã§ïŒæ¥ïŒå
ããæ°åéçµå£æäžã奜ãŸããã¯éèå æäžãã
ãããã¡ããåèšããããã«ãæäžéã¯çš®ã ã®æ¡
件ã§å€åããã®ã§ãäžèšæäžéç¯å²ããå°ãªãé
ã§ååãªå ŽåããããããŸãç¯å²ãè¶ããŠå¿ èŠãª
å Žåãããã æ¬çºæã«ããçµå£æäžã®ããã®åºäœçµæç©ãšã
ãŠã¯ãé å€ãæ£å€ãé¡ç²å€çãå«ãŸããããã®ã
ããªåºäœçµæç©ã«ãããŠã¯ãã²ãšã€ãŸãã¯ãã以
äžã®æŽ»æ§ç©è³ªããå°ãªããšãã²ãšã€ã®äžæŽ»æ§ãªåž
éå€ãäŸãã°ä¹³ç³ããã³ãããŒã«ããããŠç³ãã
ãããã·ãããã«ã»ã«ããŒã¹ã埮çµæ¶ã»ã«ããŒ
ã¹ããã³ãã³ãããªããã«ãããªãã³ãã¡ã¿ã±ã€
é žã¢ã«ãã³é žãã°ãã·ãŠã ãšæ··åããããçµæç©
ã¯ãåžžæ³ã«åŸã€ãŠãäžæŽ»æ§ãªåžéå€ä»¥å€ã®æ·»å
å€ãäŸãã°ã¹ãã¢ãªã³é žãã°ãã·ãŠã ã®ãããªæœ€
æ»å€ãç¹ç¶çŽ ã°ã«ã³ã³é žã«ã«ã·ãŠã ã®ãããªåŽ©å£
å€ãå«æããŠããŠããããé å€ãŸãã¯äžžå€ã¯å¿ èŠ
ã«ããçœç³ããŒã©ãã³ãããããã·ãããã«ã»ã«
ããŒã¹ãããããã·ãããã«ã¡ãã«ã»ã«ããŒã¹ã
ã¿ã¬ãŒããªã©ã®è溶æ§ãããã¯è žæº¶æ§ç©è³ªã®ãã€
ã«ã ã§è¢«èããŠããããããŸãïŒä»¥äžã®å±€ã§è¢«è
ããŠããããããã«ãŒã©ãã³ã®ãããªåžåããã
ãç©è³ªã®ã«ãã»ã«å€ãšããŠãããã çµå£æäžã®ããã®æ¶²äœçµæç©ã¯ãè¬å€çã«èš±å®¹
ãããä¹³æ¿å€ã溶液å€ãæžæ¿å€ãã·ãããå€ããš
ãªãã·ã«å€çãå«ã¿ãäžè¬çã«çšããããäžæŽ»æ§
ãªåžéå€ãäŸãã°ç²Ÿè£œæ°Žããšã¿ããŒã«ãå«ããã
ã®çµæç©ãªäžæŽ»æ§ãªåžéå€ä»¥å€ã«æ¹¿æœ€å€ãæžæ¿å€
ã®ãããªè£å©å€ãçå³å€ã颚å³å€ãè³éŠå€ãé²è
å€ãå«æããŠããŠãããã çµå£æäžã®ãããã®ä»ã®çµæç©ãšããŠã¯ãã²ãš
ã€ãŸãã¯ãã以äžã®æŽ»æ§ç©è³ªãå«ã¿ãããèªäœå ¬
ç¥ã®æ¹æ³ã«ããåŠæ¹ãããã¹ãã¬ãŒå€ãå«ãŸã
ãã æ¬çºæã«ããéçµå£æäžã®ããã®æ³šå°å€ãšããŠ
ã¯ãç¡èã®æ°Žæ§ãŸãã¯éæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ã
ä¹³æ¿å€ãå å«ãããæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ãšããŠ
ã¯äŸãã°æ³šå°çšèžçæ°Žåã³ççé£å¡©æ°Žãå«ãŸã
ããéæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ãšããŠã¯ãäŸãã°ã
ããã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ã
ãªãªãŒãæ²¹ã®ãããªæ€ç©æ²¹ãã¡ã¿ããŒã«ã®ãããª
ã¢ã«ã³ãŒã«é¡ãããªãœã«ããŒã80çãããããã®
ãããªçµæç©ã¯ãããã«é²è å€ã湿最å€ãä¹³å
å€ãåæ£å€ã®ãããªè£å©å€ãå«ãã§ãããããã
ãã¯äŸãã°ãã¯ããªã¢ä¿çãã€ã«ã¿ãŒãéã
éã殺èå€ã®é åãŸãã¯ç §å°ã«ãã€ãŠç¡èåãã
ãããããã¯ãŸãç¡èã®åºäœçµæç©ã補é ãã䜿
çšåã«ç¡èæ°ŽãŸãã¯ç¡èã®æ³šå°çšæº¶åªã«æº¶è§£ããŠ
䜿çšããããšãã§ããã éçµå£æäžã®ããã®ãã®ä»ã®çµæç©ãšããŠã¯ã
ã²ãšã€ãŸãã¯ãã以äžã®æŽ»æ§ç©è³ªãå«ã¿ãããèª
äœå ¬ç¥ã®æ¹æ³ã«ããåŠæ¹ãããå€çšæ¶²å€ãè»ã³ãŠ
ã®ãããªå¡åžå€ãçŽè žå æäžã®ããã®åå€åã³è£
å æäžã®ããã®ãããµãªãŒçãå«ãŸããã æ¬çºæã«å«ãŸããäžè¬åŒïŒïŒ¡ïŒãŸãã¯ïŒ
ïŒã§ç€ºãããååç©ã®ãã¡ã奜ãŸãããã®ãšã
ãŠã¯ãäŸãã° 20âãã«âPGD2ã¢ã«ã³ãŒã«ã PGD2ã¢ã«ã³ãŒã«ã 16âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 17âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 18âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 16ïŒ16âãžã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 16âãšãã«âPGD2ã¢ã«ã³ãŒã«ã 17âãšãã«âPGD2ã¢ã«ã³ãŒã«ã 20âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 16ïŒ20âãžã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 17ïŒ20âãžã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 16âãšãã«â20âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ã 17âãšãã«â20âã¡ãã«âPGD2ã¢ã«ã³ãŒã«ãã 20âãšãã«âPGD2ã¢ã«ã³ãŒã«ã 17âã¡ãã«â20âãšãã«âPGD2ã¢ã«ã³ãŒã«ã 17ïŒ20âãžãšãã«âPGD2ã¢ã«ã³ãŒã«ã 20âãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³ãŒ
ã«ã ïŒâããªãã·âÎ9âPGD2ã¢ã«ã³ãŒã«ã 16âã¡ãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 17âã¡ãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 18âã¡ãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 16ïŒ16âãžã¡ãã«âïŒâããªãã·âÎ9âPGD2
ã¢ã«ã³ãŒã«ã 16âãšãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 17âãšãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 20âã¡ãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 16ïŒ20âãžã¡ãã«âïŒâããªãã·âÎ9âPGD2
ã¢ã«ã³ãŒã«ã 17ïŒ20âãžã¡ãã«âïŒâããªãã·âÎ9âPGD2
ã¢ã«ã³ãŒã«ã 16âãšãã«â20âã¡ãã«âïŒâããªãã·âÎ9
âPGD2ã¢ã«ã³ãŒã«ã 17âãšãã«â20âã¡ãã«âïŒâããªãã·âÎ9
âPGD2ã¢ã«ã³ãŒã«ã 20âãšãã«âïŒâããªãã·âÎ9âPGD2ã¢ã«ã³
ãŒã«ã 17âã¡ãã«â20âãšãã«âïŒâããªãã·âÎ9
âPGD2ã¢ã«ã³ãŒã«ã 17ïŒ20âãžãšãã«âïŒâããªãã·âÎ9âPGD2
ã¢ã«ã³ãŒã«ã ãæããããã 以äžãåèäŸåã³å®æœäŸã«ããæ¬çºæã詳述ã
ãããæ¬çºæã¯ãããã®å®æœäŸã«éå®ããããã®
ã§ã¯ãªãããªãåèäŸåã³å®æœäŸäžã®ãTLCãã
ãNMRãããIRãåã³ãMassãã¯ãåã ãèå±€ã¯
ãããã°ã©ãã€ããæ žç£æ°å ±é³Žã¹ãã¯ãã«ãããèµ€
å€åžåã¹ãã¯ãã«ãåã³ã質éåæããè¡šããã
ãŸãæ§é åŒäžã®BMSãTHPåã³Msã¯ãåã tert
âããã«ãžã¡ãã«ã·ãªã«åºãããã©ããããã©ã³
âïŒâã€ã«åºåã³ã¡ã·ã«åºïŒã¡ã¿ã³ã¹ã«ããã«
åºïŒãè¡šãããã¯ãããã°ã©ãã€ã«ããåé¢ã®ç®
æã«èšèŒãããŠããã«ãã³å ã®æº¶åªã¯äœ¿çšãã溶
åºæº¶åªãŸãã¯å±é溶åªã瀺ããç¹å¥ã®èšèŒããªã
å Žåã«ã¯ãIRã¯æ¶²èæ³ã§æž¬å®ããNMRã¯éã¯ã
ããã«ã ïŒCDCl3ïŒæº¶æ¶²ã§æž¬å®ããŠããã åèäŸ ïŒ ã®åæ 也ç¥ããªãžã³55mlã«æº¶ãããïŒ5ZïŒ13EïŒâ
ïŒ9αïŒ11αïŒ15SïŒâïŒïŒ11âãžããããã·â15â
ïŒããã©ããããã©ã³âïŒâã€ã«ãªãã·ïŒããã¹
ã¿ãŒïŒïŒ13âãžãšã³é žã¡ãã«ãšã¹ãã«ç¹éæ59â
1463å·æ现æžåèäŸïŒèšèŒã®ååç©ïŒïŒïœã«ããž
ã¡ãã«ã¢ããããªãžã³134mgåã³tertâããã«ãž
ã¡ãã«ã¯ããã·ã©ã³8.33ïœãå ãã35âã§ïŒæé
ãããŸãããåå¿æ··åç©ã«ãžãšãã«ãšãŒãã«500
mlãå ããåŸãæ°Žãå·ïŒèŠå®å¡©é žãæ°Žåã³é£œåé£
å¡©æ°Žã§é 次æŽæµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥
åŸæžå§æ¿çž®ãããæ®çç©ãã·ãªã«ã²ã«ã«ã©ã ã¯ã
ããã°ã©ãã€ïŒïœâãããµã³ãšé ¢é žãšãã«ã®æ··å
液ã次ãã§é ¢é žãšãã«ã®ã¿ïŒã§ç²Ÿè£œããŠã次ã®ç©
æ§å€ãæããæšé¡ååç©6.6ïœïŒäžéšäžçŽç©ãå«
ãïŒãåŸãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒRf
ïŒ0.74ïŒ NMRïŒÎŽïŒ5.5ã5.1ïŒ4HïŒïœïŒã4.7ã4.5ïŒ1HïŒ
ïœïŒã4.3ã3.2ïŒ5HïŒïœïŒã3.6ïŒ3HïŒïœïŒã0.9
ïŒ9HïŒïœïŒã1.0ã0.8ïŒ3HïŒïœïŒïŒ IRïŒÎœïŒ3500ã2930ã1735ã1250ã1015ã975cm
-1ïŒ MassïŒïœïŒïœ ïŒ509ã407ã åèäŸ ïŒ ã®åæ å¡©åã¡ãã¬ã³56mlã«æº¶ãããïŒâããããã·äœ
ïŒåèäŸïŒã§è£œé ãããïŒ6.6ïœã«ã宀枩ã§ïŒïŒïŒ
âãžããããã©ã³3.16mlåã³ïœâãã«ãšã³ã¹ã«ã
ã³é žïŒæ°Žåç©68.5mgãå ããå枩床ã§ïŒæéãã
ãŸãããåå¿æ··åç©ã«ããªãšãã«ã¢ãã³ãå ããŠ
PHïŒã«èª¿æŽããåŸããžãšãã«ãšãŒãã«300mlãå
ããæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽæµããç¡æ°Žç¡«é žã
ã°ãã·ãŠã ã§ä¹Ÿç¥æžå§æ¿çž®ãããæ®çç©ãã·ãªã«
ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ïŒïœâãããµã³ã次
ãã§ïœâãããµã³ãšé ¢é žãšãã«ã®æ··å液ïŒã§ç²Ÿè£œ
ããŠã次ã®ç©æ§å€ãæããæšé¡ååç©6.3ïœãåŸ
ãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒRf
ïŒ0.40ïŒ NMRïŒÎŽïŒ5.6ã5.0ïŒ4HïŒïœïŒã4.7ã4.4ïŒ2HïŒ
ïœïŒã4.3ã3.1ïŒ7HïŒïœïŒã3.6ïŒ3HïŒïœïŒã0.9
ïŒ12HïŒïœåã³ïœïŒïŒ IRïŒÎœïŒ2920ã2850ã1740ã1450ã1250ã1120ã
1020ã985cm-1ïŒ MassïŒïœïŒïœ ïŒ598ã548ã509ã491ã åèäŸ ïŒ ã®åæ å¡©åã¡ãã¬ã³60mlã«æº¶ãããïŒâããããã·äœ
ïŒåèäŸïŒã§è£œé ãããïŒ7.13ïœã«ãããªãšãã«ã¢
ãã³6.6mlãâ30âã§å ããããã«ã¡ã·ã«ã¯ãã©
ã€ã3.1mlã滎äžããå枩床ã§40åéã次ãã§ïŒ
âã§20åéãããŸãããåå¿æ··åç©ã«æ°Ž50mlåã³
å¡©åã¡ãã¬ã³150mlãå ããŠãå¡©åã¡ãã¬ã³å±€ã
飜åé£å¡©æ°Žã§æŽæµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿ
ç¥åŸæžå§æ¿çž®ãããæ®çç©ãã·ãªã«ã²ã«ã«ã©ã ã¯
ãããã°ã©ãã€ïŒé ¢é žãšãã«ãšïœâãããµã³ã®æ··
å液ïŒã§ç²Ÿè£œãã次ã®ç©æ§å€ãæããæšé¡ååç©
6.93ïœãåŸãã TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.42ïŒ NMRïŒCCl4溶液ïŒïŒÎŽïŒ5.7ã5.2ïŒ4HïŒïœïŒã4.9
ïŒ1HïŒïœïŒã4.6ïŒ1HïŒïœïŒã3.6ïŒ3HïŒïœïŒã2.9
ïŒ3HïŒïœïŒã0.9ïŒ9HïŒïœïŒã0.1ïŒ6HïŒïœïŒïŒ IRïŒÎœïŒ2940ã1740ã1358ã1173ã912cm-1ïŒ åèäŸ ïŒ
ãåŒãã®åæ
ããã©ããããã©ã³50mlã«æº¶ãããã¡ãã«ãšã¹
ãã«äœïŒåèäŸïŒã§è£œé ãããïŒ6.3ïœã«ããã«ãš
ã³ã«æº¶ããããžã€ãœããã«ã¢ã«ãããŠã ãã€ãã©
ã€ãã®1.76MïŒã¢ã«ïŒæº¶æ¶²12mlãïŒâã§æ»Žäžãã
å枩床ã§30åéãããŸããåŸãã¡ã¿ããŒã«5.2ml
ãå ãå枩床ã§10åéãããŸããåŸãæ°ŽïŒmlãå
ãæ¿ãããããŸããªãã35âãŸã§ææž©ããå枩床
ã§30åéãããŸãããåå¿æ··åç©ãç¡«é žãã°ãã·
ãŠã ã®å±€ãéããŠéãã液ãæžå§æ¿çž®ããŠæ¬¡
ã®ç©æ§å€ãæããæšé¡ååç©5.64ïœãç²çæç©ãš
ããŠåŸãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒRf
ïŒ0.13ïŒ NMRïŒÎŽïŒ5.6ã5.1ïŒ4HïŒïœïŒã4.8ã4.4ïŒ2HïŒ
ïœïŒã4.4ã3.2ïŒ9HïŒïœïŒã0.9ïŒ12HïŒïœåã³
ïœïŒïŒ IRïŒÎœïŒ3500ã2930ã2850ã1460ã1255ã1130ã
1020ã985cm-1ã åèäŸïŒãšåæ§ã«ããŠã次ã®ååç©ãåŸãã åºçºç©è³ªïŒåèäŸïŒã§è£œé ããã¡ãã«ãšã¹ãã«
äœïŒ TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.19ïŒ NMRïŒÎŽïŒ5.6ã5.3ïŒ4HïŒïœïŒã5.1ã4.9ïŒ1HïŒ
ïœïŒã4.8ã4.6ïŒ1HïŒïœïŒã4.2ã3.3ïŒ6HïŒïœïŒã
2.97ïŒ3HïŒïœïŒã0.83ïŒ9HïŒïœïŒïŒ IRïŒÎœïŒ3650ã3100ã2930ã2850ã1460ã1350ã
1255ã1170ã1110ã970cm-1ã åèäŸ ïŒ ã®åæ å¡©åã¡ãã¬ã³13mlã«æº¶ãããã¢ã«ã³ãŒã«äœïŒå
èäŸïŒã§è£œé ãããïŒ1.72ïœã«ãïŒïŒïŒâãžãã
ããã©ã³0.49mlåã³ïœâãã«ãšã³ã¹ã«ãã³é žïŒæ°Ž
åç©5.1mgãå ãã27âã§ïŒåéãããŸãããå
å¿æ··åç©ã«ããªãšãã«ã¢ãã³ãå ããŠãPHïŒã«èª¿
æŽããåŸæžå§æ¿çž®ãããåŸãããæ®çç©ããã¢ã«
ãŽã³é°å²æ°äžã§ä¹Ÿç¥ããã©ããããã©ã³13mlã«æº¶
ãããããã©ããã«ã¢ã³ã¢ããŠã ã¯ãã©ã€ã1.4
ïœãå ãã25âã§ïŒæéãããã«35âã§30åéã
ããŸãããåå¿æ··åç©ã«ãžãšãã«ãšãŒãã«200ml
ãå ããæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽæµããç¡æ°Žç¡«
é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ãããæ®çç©ã
ã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ïŒïœâãããµ
ã³ãšé ¢é žãšãã«ã®æ··å液ã次ãã§é ¢é žãšãã«ã®
ã¿ïŒã§ç²Ÿè£œããŠã次ã®ç©æ§å€ãæããæšé¡ååç©
1.4ïœãåŸãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒRf
ïŒ0.11ïŒ NMRïŒÎŽïŒ5.6ã5.1ïŒ4HïŒïœïŒã4.7ã4.4ïŒ3HïŒ
ïœïŒã4.4ã3.1ïŒ11HïŒïœïŒïŒ IRïŒÎœïŒ3500ã2930ã2860ã1430ã1350ã1200ã
1130ã1020ã980cm-1ïŒ MassïŒïœïŒïœ ïŒ490ã406ã388ã åèäŸïŒãšåæ§ã«ããŠã次ã®ååç©ãåŸãã åºçºç©è³ªïŒåèäŸïŒ(a)ã§è£œé ããã¢ã«ã³ãŒã«äœïŒ TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.04ïŒ NMRïŒÎŽïŒ5.7ã5.15ïŒ4HïŒïœïŒã5.15ã4.9ïŒ1HïŒ
ïœïŒã4.8ã4.4ïŒ2HïŒïœïŒã4.2ã3.0ïŒ8HïŒïœïŒã
3.0ïŒ3HïŒïœïŒïŒ IRïŒÎœïŒ3650ã3100ã2940ã2860ã1450ã1350ã
1170ã1120ã1020ã970cm-1ïŒ MassïŒïœïŒïœ ïŒ370ã304ã286ã åèäŸ ïŒ ã®åæ ã¢ã«ãŽã³é°å²æ°äžã也ç¥å¡©åã¡ãã¬ã³59mlã«æº¶
ãããããªãžã³3.81mlã«å®€æž©ã§äžé žåã¯ãã 2.36
ïœãæ¿ãããããŸããªããå ãã次ãã§ã»ã©ã€ã
12ïœãå ããããã«å¡©åã¡ãã¬ã³10mlã«æº¶ããã
11âããããã·äœïŒåèäŸïŒã§è£œé ãããïŒ1.4ïœ
ãïŒâã§äžåºŠã«å ããå枩床ã§10åéãããŸã
ããåå¿æ··åç©ãã»ã©ã€ããéããŠéãã液
ã飜åç¡«é žé 氎溶液ãæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽ
æµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®
ãã次ã«ç©æ§å€ãæããæšé¡ååç©1.33ïœãç²ç
æç©ãšããŠåŸãã TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.29ïŒ IRïŒÎœïŒ2930ã2860ã1740ã1200ã1130ã1075ã
980cm-1ã åèäŸ ïŒ ã®åæ ã¢ã«ãŽã³é°å²æ°äžã也ç¥å¡©åã¡ãã¬ã³11mlã«æº¶
ãããã·ãŠãŠé žã¯ãã©ã€ã0.5mlã«ã也ç¥å¡©åã¡
ãã¬ã³1.1mlã«æº¶ããããžã¡ãã«ã¹ã«ããã·ã
0.81mlãâ50ãâ60âã§æ»Žäžããå枩床ã§10åé
ãããŸããããã®æº¶æ¶²ã«ä¹Ÿç¥å¡©åã¡ãã¬ã³ïŒmlã«
溶ããã11âããããã·äœãåèäŸïŒ(a)ã§è£œé ã
ããã2.24ïœãâ50ãâ60âã§æ»Žäžããå枩床ã§
20åéãããŸãããããã«ãã®æº¶æ¶²ã«ããªãšãã«
ã¢ãã³3.19mlãâ50ãâ60âã§æ»Žäžããå枩床ã§
ïŒåéãããã«å®€æž©ã§30åéãããŸãããåå¿æ··
åç©ãæ°·æ°Ž100mläžã«æ³šãããžãšãã«ãšãŒãã«250
mlã§æœåºããæœåºæ¶²ãæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽ
æµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ã
ãŠã次ã®ç©æ§å€ãæããæšé¡ååç©2.25ïœãç²ç
æç©ãšããŠåŸãã TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.70ïŒ NMRïŒÎŽïŒ7.45ïŒ1HïŒddïŒã6.05ïŒ1HïŒddïŒã5.8
ã5.0ïŒ4HïŒïœïŒã4.8ã4.45ïŒ2HïŒïœïŒã4.3ã3.0
ïŒ7HïŒïœïŒïŒ IRïŒÎœïŒ2940ã2860ã1710ã1590ã1450ã1350ã
1120ã1080ã1030ã980cm-1ã å®æœäŸ ïŒ
ãã«äœïŒåèäŸïŒã§è£œé ãããïŒ6.3ïœã«ããã«ãš
ã³ã«æº¶ããããžã€ãœããã«ã¢ã«ãããŠã ãã€ãã©
ã€ãã®1.76MïŒã¢ã«ïŒæº¶æ¶²12mlãïŒâã§æ»Žäžãã
å枩床ã§30åéãããŸããåŸãã¡ã¿ããŒã«5.2ml
ãå ãå枩床ã§10åéãããŸããåŸãæ°ŽïŒmlãå
ãæ¿ãããããŸããªãã35âãŸã§ææž©ããå枩床
ã§30åéãããŸãããåå¿æ··åç©ãç¡«é žãã°ãã·
ãŠã ã®å±€ãéããŠéãã液ãæžå§æ¿çž®ããŠæ¬¡
ã®ç©æ§å€ãæããæšé¡ååç©5.64ïœãç²çæç©ãš
ããŠåŸãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒRf
ïŒ0.13ïŒ NMRïŒÎŽïŒ5.6ã5.1ïŒ4HïŒïœïŒã4.8ã4.4ïŒ2HïŒ
ïœïŒã4.4ã3.2ïŒ9HïŒïœïŒã0.9ïŒ12HïŒïœåã³
ïœïŒïŒ IRïŒÎœïŒ3500ã2930ã2850ã1460ã1255ã1130ã
1020ã985cm-1ã åèäŸïŒãšåæ§ã«ããŠã次ã®ååç©ãåŸãã åºçºç©è³ªïŒåèäŸïŒã§è£œé ããã¡ãã«ãšã¹ãã«
äœïŒ TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.19ïŒ NMRïŒÎŽïŒ5.6ã5.3ïŒ4HïŒïœïŒã5.1ã4.9ïŒ1HïŒ
ïœïŒã4.8ã4.6ïŒ1HïŒïœïŒã4.2ã3.3ïŒ6HïŒïœïŒã
2.97ïŒ3HïŒïœïŒã0.83ïŒ9HïŒïœïŒïŒ IRïŒÎœïŒ3650ã3100ã2930ã2850ã1460ã1350ã
1255ã1170ã1110ã970cm-1ã åèäŸ ïŒ ã®åæ å¡©åã¡ãã¬ã³13mlã«æº¶ãããã¢ã«ã³ãŒã«äœïŒå
èäŸïŒã§è£œé ãããïŒ1.72ïœã«ãïŒïŒïŒâãžãã
ããã©ã³0.49mlåã³ïœâãã«ãšã³ã¹ã«ãã³é žïŒæ°Ž
åç©5.1mgãå ãã27âã§ïŒåéãããŸãããå
å¿æ··åç©ã«ããªãšãã«ã¢ãã³ãå ããŠãPHïŒã«èª¿
æŽããåŸæžå§æ¿çž®ãããåŸãããæ®çç©ããã¢ã«
ãŽã³é°å²æ°äžã§ä¹Ÿç¥ããã©ããããã©ã³13mlã«æº¶
ãããããã©ããã«ã¢ã³ã¢ããŠã ã¯ãã©ã€ã1.4
ïœãå ãã25âã§ïŒæéãããã«35âã§30åéã
ããŸãããåå¿æ··åç©ã«ãžãšãã«ãšãŒãã«200ml
ãå ããæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽæµããç¡æ°Žç¡«
é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ãããæ®çç©ã
ã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ïŒïœâãããµ
ã³ãšé ¢é žãšãã«ã®æ··å液ã次ãã§é ¢é žãšãã«ã®
ã¿ïŒã§ç²Ÿè£œããŠã次ã®ç©æ§å€ãæããæšé¡ååç©
1.4ïœãåŸãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒRf
ïŒ0.11ïŒ NMRïŒÎŽïŒ5.6ã5.1ïŒ4HïŒïœïŒã4.7ã4.4ïŒ3HïŒ
ïœïŒã4.4ã3.1ïŒ11HïŒïœïŒïŒ IRïŒÎœïŒ3500ã2930ã2860ã1430ã1350ã1200ã
1130ã1020ã980cm-1ïŒ MassïŒïœïŒïœ ïŒ490ã406ã388ã åèäŸïŒãšåæ§ã«ããŠã次ã®ååç©ãåŸãã åºçºç©è³ªïŒåèäŸïŒ(a)ã§è£œé ããã¢ã«ã³ãŒã«äœïŒ TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.04ïŒ NMRïŒÎŽïŒ5.7ã5.15ïŒ4HïŒïœïŒã5.15ã4.9ïŒ1HïŒ
ïœïŒã4.8ã4.4ïŒ2HïŒïœïŒã4.2ã3.0ïŒ8HïŒïœïŒã
3.0ïŒ3HïŒïœïŒïŒ IRïŒÎœïŒ3650ã3100ã2940ã2860ã1450ã1350ã
1170ã1120ã1020ã970cm-1ïŒ MassïŒïœïŒïœ ïŒ370ã304ã286ã åèäŸ ïŒ ã®åæ ã¢ã«ãŽã³é°å²æ°äžã也ç¥å¡©åã¡ãã¬ã³59mlã«æº¶
ãããããªãžã³3.81mlã«å®€æž©ã§äžé žåã¯ãã 2.36
ïœãæ¿ãããããŸããªããå ãã次ãã§ã»ã©ã€ã
12ïœãå ããããã«å¡©åã¡ãã¬ã³10mlã«æº¶ããã
11âããããã·äœïŒåèäŸïŒã§è£œé ãããïŒ1.4ïœ
ãïŒâã§äžåºŠã«å ããå枩床ã§10åéãããŸã
ããåå¿æ··åç©ãã»ã©ã€ããéããŠéãã液
ã飜åç¡«é žé 氎溶液ãæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽ
æµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®
ãã次ã«ç©æ§å€ãæããæšé¡ååç©1.33ïœãç²ç
æç©ãšããŠåŸãã TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.29ïŒ IRïŒÎœïŒ2930ã2860ã1740ã1200ã1130ã1075ã
980cm-1ã åèäŸ ïŒ ã®åæ ã¢ã«ãŽã³é°å²æ°äžã也ç¥å¡©åã¡ãã¬ã³11mlã«æº¶
ãããã·ãŠãŠé žã¯ãã©ã€ã0.5mlã«ã也ç¥å¡©åã¡
ãã¬ã³1.1mlã«æº¶ããããžã¡ãã«ã¹ã«ããã·ã
0.81mlãâ50ãâ60âã§æ»Žäžããå枩床ã§10åé
ãããŸããããã®æº¶æ¶²ã«ä¹Ÿç¥å¡©åã¡ãã¬ã³ïŒmlã«
溶ããã11âããããã·äœãåèäŸïŒ(a)ã§è£œé ã
ããã2.24ïœãâ50ãâ60âã§æ»Žäžããå枩床ã§
20åéãããŸãããããã«ãã®æº¶æ¶²ã«ããªãšãã«
ã¢ãã³3.19mlãâ50ãâ60âã§æ»Žäžããå枩床ã§
ïŒåéãããã«å®€æž©ã§30åéãããŸãããåå¿æ··
åç©ãæ°·æ°Ž100mläžã«æ³šãããžãšãã«ãšãŒãã«250
mlã§æœåºããæœåºæ¶²ãæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽ
æµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ã
ãŠã次ã®ç©æ§å€ãæããæšé¡ååç©2.25ïœãç²ç
æç©ãšããŠåŸãã TLCïŒé ¢é žãšãã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒïŒRf
ïŒ0.70ïŒ NMRïŒÎŽïŒ7.45ïŒ1HïŒddïŒã6.05ïŒ1HïŒddïŒã5.8
ã5.0ïŒ4HïŒïœïŒã4.8ã4.45ïŒ2HïŒïœïŒã4.3ã3.0
ïŒ7HïŒïœïŒïŒ IRïŒÎœïŒ2940ã2860ã1710ã1590ã1450ã1350ã
1120ã1080ã1030ã980cm-1ã å®æœäŸ ïŒ
ãåŒãã®åæ
ããã©ããããã©ã³3.1mlã«æº¶ãããïŒïŒïŒïŒ
15âããªã¹âTHPäœïŒåèäŸïŒã§è£œé ãããïŒ
920mgã«65ïŒ é ¢é žæ°Žæº¶æ¶²15.6mlãå ãã80âã§ïŒ
åéãããŸãããåå¿æ··åç©ã«é ¢é žãšãã«350ml
ãå ããå·ãããªããæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽ
æµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ã
ããæ®çç©ãã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€
ïŒé ¢é žãšãã«ãšïœâãããµã³ã®æ··å液ã次ãã§é ¢
é žãšãã«ã®ã¿ïŒã§ç²Ÿè£œããããã«ãžãšãã«ãšãŒã
ã«ãšïœâãããµã³ã®æ··å液ããåçµæ¶ãã次ã®ç©
æ§å€ãæããæšé¡ååç©115mgãåŸãã èç¹ïŒ45âïŒ TLCïŒã¯ãããã«ã ïŒããã©ããããã©ã³ïŒé ¢é ž
ïŒ10ïŒïŒïŒïŒïŒïŒRfïŒ0.29ïŒ NMRïŒÎŽïŒ5.63ïŒ1HïŒddïŒã5.42ïŒ1HïŒddïŒã5.65
ã5.35ïŒ2HïŒïœïŒã4.55ã4.4ïŒ1HïŒïœïŒã4.09
ïŒ1HïŒdtïŒã3.66ïŒ2HïŒïœïŒã2.85ïŒ1HïŒddïŒã
2.43ïŒ2HïŒïœïŒïŒ IRïŒÎœïŒ3370ã2920ã2850ã1720ã1410ã1310ã
1150ã1055ã970cm-1ïŒ MassïŒïœïŒïœ ïŒ338ïŒM+ïŒã320ã302ã267ã249ã
231ã å®æœäŸïŒãšåæ§ã«ããŠæ¬¡ã®ååç©ãåŸãã åºçºç©è³ªïŒåèäŸïŒã§è£œé ããïŒïŒ15âãã¹
THPäœïŒ TLCïŒã¯ãããã«ã ïŒããã©ããããã©ã³ïŒé ¢é ž
ïŒ10ïŒïŒïŒïŒïŒïŒRfïŒ0.45ïŒ NMRïŒÎŽïŒ7.58ïŒ1HïŒddïŒã6.15ïŒ1HïŒddïŒã5.67
ïŒ1HïŒddïŒã5.55ïŒ1HïŒddïŒã5.7ã5.3ïŒ2HïŒ
ïœïŒã4.09ïŒ1HïŒdtïŒã3.64ïŒ2HïŒïœïŒã2.9ã2.75
ïŒ1HïŒïœïŒã2.66ïŒ1HïŒddïŒïŒ IRïŒÎœïŒ3650ã3100ã2930ã2860ã1705ã1590ã
1460ã1350ã1165ã1050ã970cm-1ïŒ MassïŒïœïŒïœ ïŒ320ïŒM+ïŒã302ã249ã231ã43ã åèäŸ ïŒ ãšã¿ããŒã«ïŒmlã«æº¶è§£ããPGD2ã¢ã«ã³ãŒã«ïŒ
ïœã埮çµæ¶ã»ã«ããŒã¹ïŒïœã«ããæ··åããåå也
ç¥ãããåŸãã¹ãã¢ãªã³é žãã°ãã·ãŠã 100mgã
äºé žåã±ã€çŽ 20mgãã¿ã«ã¯10mgãç¹ç¶çŽ ã°ã«ã³ã³
é žã«ã«ã·ãŠã ïŒECGïŒ200mgãå ããããã«åŸ®çµ
æ¶ã»ã«ããŒã¹ãå ããŠå šéã10ïœãšããåäžã«ãª
ããŸã§ããæ··åããåŸãåžžæ³ã«ããæé ããŠãäž
é äžã«10mgã®æŽ»æ§ç©è³ªãå«ãé å€100é ãåŸãã åèäŸ ïŒ PGD2ã¢ã«ã³ãŒã«ã®Î±âã·ã¯ãããã¹ããªã³ãš
βâã·ã¯ãããã¹ããªã³ã®å æ¥ååç©ãαâã·ã¯
ãããã¹ããªã³2.4ïœåã³Î²âã·ã¯ãããã¹ããª
ã³ïŒïœãæ°Ž300mlã«æº¶è§£ãããããã«PGD2ã¢ã«
ã³ãŒã«100mgãå ããŠååã«ãããŸããåŸæžå§æ¿
çž®ããŠè£œé ããããã泚å°çšèžçæ°Ž150mlã«æº¶è§£
ããåžžæ³ã«ããç¡èéããïŒmlã¢ã³ãã«ã«1.5
mlãã€å泚ããåçµä¹Ÿç¥ããããšã«ãããïŒã¢ã³
ãã«äžã«ïŒmgã®æŽ»æ§ç©è³ªãå«ã泚å°çšåºå補å€
100æ¬ãåŸãã åèäŸ 10 åèäŸïŒåã³ïŒãšåæ§ã«ããŠãïŒâããªãã·â
Î9âPGD2ã¢ã«ã³ãŒã«ã掻æ§æåãšããŠå«æãã
é å€åã³æ³šå°çšåºå補å€ãåŸãã
15âããªã¹âTHPäœïŒåèäŸïŒã§è£œé ãããïŒ
920mgã«65ïŒ é ¢é žæ°Žæº¶æ¶²15.6mlãå ãã80âã§ïŒ
åéãããŸãããåå¿æ··åç©ã«é ¢é žãšãã«350ml
ãå ããå·ãããªããæ°Žåã³é£œåé£å¡©æ°Žã§é 次æŽ
æµããç¡æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ã
ããæ®çç©ãã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€
ïŒé ¢é žãšãã«ãšïœâãããµã³ã®æ··å液ã次ãã§é ¢
é žãšãã«ã®ã¿ïŒã§ç²Ÿè£œããããã«ãžãšãã«ãšãŒã
ã«ãšïœâãããµã³ã®æ··å液ããåçµæ¶ãã次ã®ç©
æ§å€ãæããæšé¡ååç©115mgãåŸãã èç¹ïŒ45âïŒ TLCïŒã¯ãããã«ã ïŒããã©ããããã©ã³ïŒé ¢é ž
ïŒ10ïŒïŒïŒïŒïŒïŒRfïŒ0.29ïŒ NMRïŒÎŽïŒ5.63ïŒ1HïŒddïŒã5.42ïŒ1HïŒddïŒã5.65
ã5.35ïŒ2HïŒïœïŒã4.55ã4.4ïŒ1HïŒïœïŒã4.09
ïŒ1HïŒdtïŒã3.66ïŒ2HïŒïœïŒã2.85ïŒ1HïŒddïŒã
2.43ïŒ2HïŒïœïŒïŒ IRïŒÎœïŒ3370ã2920ã2850ã1720ã1410ã1310ã
1150ã1055ã970cm-1ïŒ MassïŒïœïŒïœ ïŒ338ïŒM+ïŒã320ã302ã267ã249ã
231ã å®æœäŸïŒãšåæ§ã«ããŠæ¬¡ã®ååç©ãåŸãã åºçºç©è³ªïŒåèäŸïŒã§è£œé ããïŒïŒ15âãã¹
THPäœïŒ TLCïŒã¯ãããã«ã ïŒããã©ããããã©ã³ïŒé ¢é ž
ïŒ10ïŒïŒïŒïŒïŒïŒRfïŒ0.45ïŒ NMRïŒÎŽïŒ7.58ïŒ1HïŒddïŒã6.15ïŒ1HïŒddïŒã5.67
ïŒ1HïŒddïŒã5.55ïŒ1HïŒddïŒã5.7ã5.3ïŒ2HïŒ
ïœïŒã4.09ïŒ1HïŒdtïŒã3.64ïŒ2HïŒïœïŒã2.9ã2.75
ïŒ1HïŒïœïŒã2.66ïŒ1HïŒddïŒïŒ IRïŒÎœïŒ3650ã3100ã2930ã2860ã1705ã1590ã
1460ã1350ã1165ã1050ã970cm-1ïŒ MassïŒïœïŒïœ ïŒ320ïŒM+ïŒã302ã249ã231ã43ã åèäŸ ïŒ ãšã¿ããŒã«ïŒmlã«æº¶è§£ããPGD2ã¢ã«ã³ãŒã«ïŒ
ïœã埮çµæ¶ã»ã«ããŒã¹ïŒïœã«ããæ··åããåå也
ç¥ãããåŸãã¹ãã¢ãªã³é žãã°ãã·ãŠã 100mgã
äºé žåã±ã€çŽ 20mgãã¿ã«ã¯10mgãç¹ç¶çŽ ã°ã«ã³ã³
é žã«ã«ã·ãŠã ïŒECGïŒ200mgãå ããããã«åŸ®çµ
æ¶ã»ã«ããŒã¹ãå ããŠå šéã10ïœãšããåäžã«ãª
ããŸã§ããæ··åããåŸãåžžæ³ã«ããæé ããŠãäž
é äžã«10mgã®æŽ»æ§ç©è³ªãå«ãé å€100é ãåŸãã åèäŸ ïŒ PGD2ã¢ã«ã³ãŒã«ã®Î±âã·ã¯ãããã¹ããªã³ãš
βâã·ã¯ãããã¹ããªã³ã®å æ¥ååç©ãαâã·ã¯
ãããã¹ããªã³2.4ïœåã³Î²âã·ã¯ãããã¹ããª
ã³ïŒïœãæ°Ž300mlã«æº¶è§£ãããããã«PGD2ã¢ã«
ã³ãŒã«100mgãå ããŠååã«ãããŸããåŸæžå§æ¿
çž®ããŠè£œé ããããã泚å°çšèžçæ°Ž150mlã«æº¶è§£
ããåžžæ³ã«ããç¡èéããïŒmlã¢ã³ãã«ã«1.5
mlãã€å泚ããåçµä¹Ÿç¥ããããšã«ãããïŒã¢ã³
ãã«äžã«ïŒmgã®æŽ»æ§ç©è³ªãå«ã泚å°çšåºå補å€
100æ¬ãåŸãã åèäŸ 10 åèäŸïŒåã³ïŒãšåæ§ã«ããŠãïŒâããªãã·â
Î9âPGD2ã¢ã«ã³ãŒã«ã掻æ§æåãšããŠå«æãã
é å€åã³æ³šå°çšåºå補å€ãåŸãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ åŒäžãããã¯ãåŒ ãåŒã ãŸã㯠ãåŒã ã§ç€ºãããåºãè¡šãããR1ã¯ççŽ æ°ïŒãïŒã®çŽ
éãŸãã¯åæéã¢ã«ãã«åºãè¡šãããC5âC6é
ã®äºéçµåã¯ïŒºãè¡šãããC13âC14éã®äºéçµå
ã¯ïŒ¥ãè¡šãããåŒïŒïŒã«ãããŠãC9âC10éã®
äºéçµåã¯ïŒºãè¡šããã ã§ç€ºãããããã¹ã¿ã°ã©ã³ãžã³ïŒ€é¡äŒŒååç©ããŸ
ãã¯ãããã®ã·ã¯ãããã¹ããªã³å æ¥ååç©ã ïŒ ãããåŒïŒïŒã§ç€ºãããåºãè¡šããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ååç©ãPGD2ã¢ã«ã³ãŒã«ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ãããåŒïŒïŒã§ç€ºãããåºãè¡šããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ååç©ãïŒâããªãã·âÎ9âPGD2ã¢ã«ã³ãŒ
ã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3817183A JPS59164769A (ja) | 1983-03-10 | 1983-03-10 | æ°èŠãªããã¹ã¿ã°ã©ã³ãžã³ïœé¡äŒŒååç© |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3817183A JPS59164769A (ja) | 1983-03-10 | 1983-03-10 | æ°èŠãªããã¹ã¿ã°ã©ã³ãžã³ïœé¡äŒŒååç© |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59164769A JPS59164769A (ja) | 1984-09-17 |
| JPH039888B2 true JPH039888B2 (ja) | 1991-02-12 |
Family
ID=12517941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3817183A Granted JPS59164769A (ja) | 1983-03-10 | 1983-03-10 | æ°èŠãªããã¹ã¿ã°ã©ã³ãžã³ïœé¡äŒŒååç© |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59164769A (ja) |
-
1983
- 1983-03-10 JP JP3817183A patent/JPS59164769A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59164769A (ja) | 1984-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4446147A (en) | Azaprostacyclins, their preparation and pharmaceutical use | |
| US4708963A (en) | Novel carbacyclins, their preparation and use | |
| EP0196380B1 (en) | Prostaglandin analogues, processes for their preparation and pharmaceutical compositions containing them | |
| GB2075976A (en) | 3-hydroxy and 3-oxo-prostaglandin analogues | |
| EP0051284B1 (en) | Novel thiaprostaglandin e1 derivatives, process for production thereof, and pharmaceuticals containing these compounds | |
| US4649156A (en) | 6-nitroprostaglandin derivatives | |
| US4954524A (en) | Carbacylcins, their preparation and use as medicinal agents | |
| US4562204A (en) | Trans-Î2 -prostaglandin D derivatives, process for their preparation and compositions containing them | |
| JPH0314304B2 (ja) | ||
| JPH0149264B2 (ja) | ||
| JPH038338B2 (ja) | ||
| US4315013A (en) | Certain pyrrole analogs of prostacyclin derivatives | |
| JPH0717597B2 (ja) | ããšããã·ããã¹ã¿ããªãšã³é žèªå°äœãšãã®è£œé æ³ | |
| JPH039888B2 (ja) | ||
| US4532236A (en) | Certain prostacyclins and their blood-pressure-lowering and thrombocyte-aggregation-inhibiting compositions and methods | |
| JPS595155A (ja) | ããã¹ã¿ã°ã©ã³ãžã³ïœé¡äŒŒååç© | |
| JPH039889B2 (ja) | ||
| US5625067A (en) | Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use | |
| US4721729A (en) | Novel carbacyclins, process for the preparation thereof, and their use as medicinal agents | |
| EP0172963A1 (en) | Prostaglandin analogues, processes for their preparation and compositions containing them | |
| US5157042A (en) | 3-oxa-5-fluoro-carbacyclins, their preparation and use as medicinal agents | |
| WO1991013869A1 (en) | 15-deoxyprostaglandin derivative | |
| US5190973A (en) | 20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals | |
| JPH039887B2 (ja) | ||
| EP0171441A1 (en) | Prostaglandin analogues, processes for their preparation and compositions containing them |